SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '211'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1AFS_A_TESA325_1 (3-ALPHA-HYDROXYSTEROID DEHYDROGENASE) |
5xyi | 40S RIBOSOMALPROTEIN SAUNCHARACTERIZEDPROTEIN (Trichomonasvaginalis) | 4 / 7 | LEU C 149TYR C 146THR A 107TYR A 109 | NoneNone G 21102 ( 3.2A) U 21101 ( 3.9A) | 1.32A | 1afsA-5xyiC:undetectable | 1afsA-5xyiC:20.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1AFS_B_TESB325_1 (3-ALPHA-HYDROXYSTEROID DEHYDROGENASE) |
5xyi | 40S RIBOSOMALPROTEIN SAUNCHARACTERIZEDPROTEIN (Trichomonasvaginalis) | 4 / 7 | LEU C 149TYR C 146THR A 107TYR A 109 | NoneNone G 21102 ( 3.2A) U 21101 ( 3.9A) | 1.32A | 1afsB-5xyiC:undetectable | 1afsB-5xyiC:20.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1AV2_A_DVAA6_0 (GRAMICIDIN A) |
2btd | PTS-DEPENDENTDIHYDROXYACETONEKINASE (Escherichiacoli) | 3 / 3 | ALA A 123VAL A 117TRP A 134 | ADP A1211 ( 4.4A)NoneNone | 0.93A | 1av2A-2btdA:undetectable1av2B-2btdA:undetectable | 1av2A-2btdA:7.521av2B-2btdA:7.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1AV2_D_DVAD6_0 (GRAMICIDIN A) |
2btd | PTS-DEPENDENTDIHYDROXYACETONEKINASE (Escherichiacoli) | 3 / 3 | TRP A 134ALA A 123VAL A 117 | NoneADP A1211 ( 4.4A)None | 0.88A | 1av2C-2btdA:undetectable1av2D-2btdA:undetectable | 1av2C-2btdA:7.521av2D-2btdA:7.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1BX4_A_ADNA350_2 (PROTEIN (ADENOSINEKINASE)) |
2x3l | ORN/LYS/ARGDECARBOXYLASE FAMILYPROTEIN (Staphylococcusaureus) | 3 / 3 | LEU A 222SER A 220ASN A 79 | NonePLP A1211 (-3.4A)None | 0.83A | 1bx4A-2x3lA:3.0 | 1bx4A-2x3lA:21.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTI_A_CCSA47_0 (GLUTATHIONES-TRANSFERASE) |
4mes | THIAMINE TRANSPORTERTHIT (Lactococcuslactis) | 4 / 7 | LEU A 10LEU A 53GLY A 52LEU A 47 | PG4 A 211 (-4.4A)NoneNoneNone | 0.94A | 1gtiA-4mesA:undetectable | 1gtiA-4mesA:22.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTN_D_TRPD81_0 (TRP RNA-BINDINGATTENUATION PROTEIN) |
1yz4 | DUAL SPECIFICITYPHOSPHATASE-LIKE 15ISOFORM A (Homosapiens) | 4 / 7 | SER A 88VAL A 61THR A 97ILE A 63 | SO4 A 211 (-2.5A)NoneNoneNone | 0.86A | 1gtnC-1yz4A:undetectable1gtnD-1yz4A:undetectable | 1gtnC-1yz4A:18.011gtnD-1yz4A:18.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HK1_A_T44A3004_1 (SERUM ALBUMIN) |
5xyi | 40S RIBOSOMALPROTEIN SA (Trichomonasvaginalis) | 4 / 6 | PHE A 101GLU A 134VAL A 72MET A 120 | None A 21131 ( 3.1A)NoneNone | 1.06A | 1hk1A-5xyiA:undetectable | 1hk1A-5xyiA:19.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1IGX_A_EPAA700_2 (PROSTAGLANDINENDOPEROXIDE HSYNTHASE-1) |
1aoa | T-FIMBRIN (Homosapiens) | 5 / 8 | VAL A 211VAL A 165SER A 203ILE A 207LEU A 230 | VAL A 211 ( 0.6A)VAL A 165 ( 0.6A)SER A 203 ( 0.0A)ILE A 207 ( 0.7A)LEU A 230 ( 0.6A) | 1.34A | 1igxA-1aoaA:undetectable | 1igxA-1aoaA:19.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1JIP_A_KTNA801_1 (CYTOCHROME P450107A1) |
2qec | HISTONEACETYLTRANSFERASEHPA2 AND RELATEDACETYLTRANSFERASES (Corynebacteriumglutamicum) | 5 / 12 | GLY A 138LEU A 174VAL A 141ALA A 144LEU A 170 | EDO A 211 (-3.3A)NoneNoneNoneNone | 1.44A | 1jipA-2qecA:undetectable | 1jipA-2qecA:20.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MJ2_A_SAMA2201_1 (PROTEIN (METHIONINEREPRESSOR)) |
5xxu | RIBOSOMAL PROTEINUS12 (Toxoplasmagondii) | 4 / 4 | HIS X 110ALA X 111PHE X 105GLY X 109 | U 21131 ( 4.3A) U 21131 ( 4.7A)NoneNone | 1.38A | 1mj2B-5xxuX:undetectable | 1mj2B-5xxuX:19.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MJO_A_SAMA199_1 (METHIONINE REPRESSOR) |
5xxu | RIBOSOMAL PROTEINUS12 (Toxoplasmagondii) | 4 / 4 | HIS X 110ALA X 111PHE X 105GLY X 109 | U 21131 ( 4.3A) U 21131 ( 4.7A)NoneNone | 1.38A | 1mjoB-5xxuX:undetectable | 1mjoB-5xxuX:19.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MJO_B_SAMB200_0 (METHIONINE REPRESSOR) |
5xxu | RIBOSOMAL PROTEINUS12 (Toxoplasmagondii) | 4 / 4 | HIS X 110ALA X 111PHE X 105GLY X 109 | U 21131 ( 4.3A) U 21131 ( 4.7A)NoneNone | 1.35A | 1mjoA-5xxuX:undetectable | 1mjoA-5xxuX:19.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MJO_D_SAMD200_1 (METHIONINE REPRESSOR) |
5xxu | RIBOSOMAL PROTEINUS12 (Toxoplasmagondii) | 4 / 4 | HIS X 110ALA X 111PHE X 105GLY X 109 | U 21131 ( 4.3A) U 21131 ( 4.7A)NoneNone | 1.41A | 1mjoD-5xxuX:undetectable | 1mjoD-5xxuX:19.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MXG_A_ACRA443_1 (ALPHA AMYLASE) |
3na8 | PUTATIVEDIHYDRODIPICOLINATESYNTHETASE (Pseudomonasaeruginosa) | 4 / 8 | SER A 187ASN A 157ASP A 165GLU A 135 | CSO A 211 ( 4.0A)NoneNoneNone | 1.09A | 1mxgA-3na8A:9.5 | 1mxgA-3na8A:23.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1OM5_A_H4BA760_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
3rq0 | GLYCOSYL HYDROLASESFAMILY PROTEIN 16 (Mycolicibacteriumsmegmatis) | 4 / 8 | VAL A 184TRP A 156TRP A 138GLU A 155 | None211 A 280 ( 4.7A)GOL A 278 (-3.7A)GOL A 278 (-3.4A) | 1.15A | 1om5A-3rq0A:undetectable1om5B-3rq0A:undetectable | 1om5A-3rq0A:20.781om5B-3rq0A:20.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1P33_A_MTXA351_1 (PTERIDINE REDUCTASE1) |
5hfi | UNCHARACTERIZEDPROTEIN, CYTOSOLICDISULFIDE REDUCTASEDSBM (Pseudomonasaeruginosa) | 5 / 12 | PHE A 206LEU A 191TYR A 196LEU A 33LEU A 211 | PHE A 206 ( 1.3A)LEU A 191 ( 0.6A)TYR A 196 ( 1.3A)LEU A 33 ( 0.6A)LEU A 211 ( 0.6A) | 1.34A | 1p33A-5hfiA:undetectable | 1p33A-5hfiA:22.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1P33_B_MTXB352_1 (PTERIDINE REDUCTASE1) |
5hfi | UNCHARACTERIZEDPROTEIN, CYTOSOLICDISULFIDE REDUCTASEDSBM (Pseudomonasaeruginosa) | 5 / 12 | PHE A 206LEU A 191TYR A 196LEU A 33LEU A 211 | PHE A 206 ( 1.3A)LEU A 191 ( 0.6A)TYR A 196 ( 1.3A)LEU A 33 ( 0.6A)LEU A 211 ( 0.6A) | 1.33A | 1p33B-5hfiA:undetectable | 1p33B-5hfiA:22.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1P33_C_MTXC353_1 (PTERIDINE REDUCTASE1) |
5hfi | UNCHARACTERIZEDPROTEIN, CYTOSOLICDISULFIDE REDUCTASEDSBM (Pseudomonasaeruginosa) | 5 / 12 | PHE A 206LEU A 191TYR A 196LEU A 33LEU A 211 | PHE A 206 ( 1.3A)LEU A 191 ( 0.6A)TYR A 196 ( 1.3A)LEU A 33 ( 0.6A)LEU A 211 ( 0.6A) | 1.29A | 1p33C-5hfiA:undetectable | 1p33C-5hfiA:22.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1P62_B_GEOB302_1 (DEOXYCYTIDINE KINASE) |
4unr | THYMIDYLATE KINASE (Mycobacteriumtuberculosis) | 5 / 11 | GLU A 124VAL A 120TYR A 179GLN A 136ARG A 74 | NoneNoneNoneNoneQZE A1211 (-2.7A) | 1.33A | 1p62B-4unrA:12.7 | 1p62B-4unrA:20.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RS6_B_H4BB761_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
3rq0 | GLYCOSYL HYDROLASESFAMILY PROTEIN 16 (Mycolicibacteriumsmegmatis) | 4 / 8 | TRP A 138GLU A 155VAL A 184TRP A 156 | GOL A 278 (-3.7A)GOL A 278 (-3.4A)None211 A 280 ( 4.7A) | 1.04A | 1rs6A-3rq0A:undetectable1rs6B-3rq0A:undetectable | 1rs6A-3rq0A:20.781rs6B-3rq0A:20.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1S14_A_NOVA1300_1 (TOPOISOMERASE IVSUBUNIT B) |
2xcm | CYTOSOLIC HEAT SHOCKPROTEIN 90 (Hordeumvulgare) | 5 / 12 | ASN A 39SER A 40ASP A 42ASP A 81THR A 173 | ADP A1211 ( 2.6A)ADP A1211 ( 4.0A)NoneADP A1211 (-3.5A)ADP A1211 (-3.4A) | 0.36A | 1s14A-2xcmA:10.1 | 1s14A-2xcmA:22.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1S14_A_NOVA1300_1 (TOPOISOMERASE IVSUBUNIT B) |
2xcm | CYTOSOLIC HEAT SHOCKPROTEIN 90 (Hordeumvulgare) | 6 / 12 | SER A 40ASP A 42ASP A 81MET A 86ASP A 144THR A 173 | ADP A1211 ( 4.0A)NoneADP A1211 (-3.5A)ADP A1211 (-3.4A)NoneADP A1211 (-3.4A) | 1.26A | 1s14A-2xcmA:10.1 | 1s14A-2xcmA:22.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1S14_B_NOVB2300_1 (TOPOISOMERASE IVSUBUNIT B) |
2xcm | CYTOSOLIC HEAT SHOCKPROTEIN 90 (Hordeumvulgare) | 5 / 12 | SER A 40ASP A 42ASP A 81MET A 86ASP A 144 | ADP A1211 ( 4.0A)NoneADP A1211 (-3.5A)ADP A1211 (-3.4A)None | 1.39A | 1s14B-2xcmA:10.8 | 1s14B-2xcmA:22.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UHO_A_VDNA1000_1 (CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 5 / 10 | TYR A 736HIS A 737PHE A 959GLN A 988PHE A 991 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A)NoneIBM A2111 (-3.3A)IBM A2111 (-3.6A) | 0.31A | 1uhoA-1sojA:34.7 | 1uhoA-1sojA:24.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1V54_C_CHDC3525_0 (CYTOCHROME C OXIDASEPOLYPEPTIDE ICYTOCHROME C OXIDASEPOLYPEPTIDE III) |
3kky | SUPEROXIDE DISMUTASE[MN] (Deinococcusradiodurans) | 4 / 7 | HIS A 26ASP A 12TYR A 9HIS A 30 | MN A 211 (-3.3A)NoneNoneNone | 1.49A | 1v54A-3kkyA:undetectable1v54C-3kkyA:undetectable | 1v54A-3kkyA:17.321v54C-3kkyA:19.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1V54_P_CHDP4525_0 (CYTOCHROME C OXIDASEPOLYPEPTIDE ICYTOCHROME C OXIDASEPOLYPEPTIDE III) |
3kky | SUPEROXIDE DISMUTASE[MN] (Deinococcusradiodurans) | 4 / 7 | HIS A 26ASP A 12TYR A 9HIS A 30 | MN A 211 (-3.3A)NoneNoneNone | 1.48A | 1v54N-3kkyA:undetectable1v54P-3kkyA:undetectable | 1v54N-3kkyA:17.321v54P-3kkyA:19.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1V55_C_CHDC3525_0 (CYTOCHROME C OXIDASEPOLYPEPTIDE ICYTOCHROME C OXIDASEPOLYPEPTIDE III) |
3kky | SUPEROXIDE DISMUTASE[MN] (Deinococcusradiodurans) | 4 / 7 | HIS A 26ASP A 12TYR A 9HIS A 30 | MN A 211 (-3.3A)NoneNoneNone | 1.49A | 1v55A-3kkyA:undetectable1v55C-3kkyA:undetectable | 1v55A-3kkyA:17.321v55C-3kkyA:19.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1W5U_A_DVAA6_0 (GRAMICIDIN D) |
2btd | PTS-DEPENDENTDIHYDROXYACETONEKINASE (Escherichiacoli) | 3 / 3 | ALA A 123VAL A 117TRP A 134 | ADP A1211 ( 4.4A)NoneNone | 0.90A | 1w5uA-2btdA:undetectable1w5uB-2btdA:undetectable | 1w5uA-2btdA:7.521w5uB-2btdA:7.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1W5U_B_DVAB6_0 (GRAMICIDIN D) |
2btd | PTS-DEPENDENTDIHYDROXYACETONEKINASE (Escherichiacoli) | 3 / 3 | TRP A 134ALA A 123VAL A 117 | NoneADP A1211 ( 4.4A)None | 0.92A | 1w5uA-2btdA:undetectable1w5uB-2btdA:undetectable | 1w5uA-2btdA:7.521w5uB-2btdA:7.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1WSV_A_THHA3001_0 (AMINOMETHYLTRANSFERASE) |
2x3l | ORN/LYS/ARGDECARBOXYLASE FAMILYPROTEIN (Staphylococcusaureus) | 5 / 12 | THR A 153ILE A 180VAL A 205PHE A 162LEU A 171 | PLP A1211 ( 4.2A)NoneNoneNoneNone | 1.06A | 1wsvA-2x3lA:0.2 | 1wsvA-2x3lA:22.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1X70_A_715A801_2 (DIPEPTIDYL PEPTIDASEIV) |
4unr | THYMIDYLATE KINASE (Mycobacteriumtuberculosis) | 3 / 3 | ARG A 38SER A 104TYR A 103 | NoneQZE A1211 (-3.3A)QZE A1211 (-3.7A) | 0.68A | 1x70A-4unrA:undetectable | 1x70A-4unrA:14.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1XL6_B_SPMB3001_1 (INWARD RECTIFIERPOTASSIUM CHANNEL) |
5xyi | 40S RIBOSOMALPROTEIN S2140S RIBOSOMALPROTEIN SA (Trichomonasvaginalis) | 4 / 5 | ALA V 30TYR A 137ALA V 60GLN A 130 | None G 21104 ( 4.6A) G 2 891 ( 3.6A) A 21131 ( 3.6A) | 1.00A | 1xl6A-5xyiV:undetectable1xl6B-5xyiV:undetectable | 1xl6A-5xyiV:13.951xl6B-5xyiV:13.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XLX_A_CIOA101_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 7 / 12 | TYR A 736HIS A 737HIS A 825THR A 952ILE A 955GLN A 988PHE A 991 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A)NoneIBM A2111 ( 4.8A)IBM A2111 (-4.2A)IBM A2111 (-3.3A)IBM A2111 (-3.6A) | 0.59A | 1xlxA-1sojA:41.6 | 1xlxA-1sojA:30.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XLX_B_CIOB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 8 / 12 | TYR A 736HIS A 737HIS A 825THR A 952ILE A 955PHE A 959GLN A 988PHE A 991 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A)NoneIBM A2111 ( 4.8A)IBM A2111 (-4.2A)NoneIBM A2111 (-3.3A)IBM A2111 (-3.6A) | 0.53A | 1xlxB-1sojA:41.8 | 1xlxB-1sojA:30.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XMU_A_ROFA101_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 5 / 12 | HIS A 737ASP A 937PRO A 941SER A 990PHE A 991 | IBM A2111 ( 4.8A) MG A2123 (-2.5A)NoneNoneIBM A2111 (-3.6A) | 1.24A | 1xmuA-1sojA:41.8 | 1xmuA-1sojA:30.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XMU_A_ROFA101_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 8 / 12 | TYR A 736HIS A 737ASP A 937PRO A 941TRP A 951ILE A 955PHE A 959PHE A 991 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A) MG A2123 (-2.5A)NoneNoneIBM A2111 (-4.2A)NoneIBM A2111 (-3.6A) | 0.57A | 1xmuA-1sojA:41.8 | 1xmuA-1sojA:30.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XMU_B_ROFB102_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 7 / 12 | TYR A 736HIS A 737ASP A 937PRO A 941TRP A 951ILE A 955PHE A 959 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A) MG A2123 (-2.5A)NoneNoneIBM A2111 (-4.2A)None | 0.48A | 1xmuB-1sojA:41.8 | 1xmuB-1sojA:30.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XOM_A_CIOA603_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 7 / 12 | TYR A 736HIS A 737ASP A 937ILE A 955PHE A 959GLN A 988PHE A 991 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A) MG A2123 (-2.5A)IBM A2111 (-4.2A)NoneIBM A2111 (-3.3A)IBM A2111 (-3.6A) | 0.54A | 1xomA-1sojA:42.2 | 1xomA-1sojA:31.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XOM_B_CIOB601_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 7 / 12 | TYR A 736HIS A 737THR A 952ILE A 955PHE A 959GLN A 988PHE A 991 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A)IBM A2111 ( 4.8A)IBM A2111 (-4.2A)NoneIBM A2111 (-3.3A)IBM A2111 (-3.6A) | 0.54A | 1xomB-1sojA:42.3 | 1xomB-1sojA:31.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XOQ_A_ROFA502_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 5 / 12 | HIS A 737ASP A 937PRO A 941SER A 990PHE A 991 | IBM A2111 ( 4.8A) MG A2123 (-2.5A)NoneNoneIBM A2111 (-3.6A) | 1.24A | 1xoqA-1sojA:42.0 | 1xoqA-1sojA:31.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XOQ_A_ROFA502_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 7 / 12 | TYR A 736HIS A 737ASP A 937PRO A 941THR A 952ILE A 955PHE A 991 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A) MG A2123 (-2.5A)NoneIBM A2111 ( 4.8A)IBM A2111 (-4.2A)IBM A2111 (-3.6A) | 0.52A | 1xoqA-1sojA:42.0 | 1xoqA-1sojA:31.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XOQ_B_ROFB501_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 5 / 12 | HIS A 737ASP A 937PRO A 941SER A 990PHE A 991 | IBM A2111 ( 4.8A) MG A2123 (-2.5A)NoneNoneIBM A2111 (-3.6A) | 1.25A | 1xoqB-1sojA:42.2 | 1xoqB-1sojA:31.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XOQ_B_ROFB501_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 8 / 12 | TYR A 736HIS A 737ASP A 937PRO A 941TRP A 951THR A 952ILE A 955PHE A 991 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A) MG A2123 (-2.5A)NoneNoneIBM A2111 ( 4.8A)IBM A2111 (-4.2A)IBM A2111 (-3.6A) | 0.52A | 1xoqB-1sojA:42.2 | 1xoqB-1sojA:31.99 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XOS_A_VIAA1_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 7 / 12 | TYR A 736HIS A 737ASP A 937PHE A 959GLN A 988PHE A 991ILE A 995 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A) MG A2123 (-2.5A)NoneIBM A2111 (-3.3A)IBM A2111 (-3.6A)None | 0.52A | 1xosA-1sojA:41.8 | 1xosA-1sojA:30.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XOS_A_VIAA1_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 6 / 12 | TYR A 736HIS A 737ASP A 937PHE A 959SER A 974GLN A 988 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A) MG A2123 (-2.5A)NoneNoneIBM A2111 (-3.3A) | 1.00A | 1xosA-1sojA:41.8 | 1xosA-1sojA:30.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XOS_A_VIAA1_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 5 / 12 | TYR A 736HIS A 741GLN A 988PHE A 991ILE A 995 | IBM A2111 (-4.5A) MG A2123 (-3.0A)IBM A2111 (-3.3A)IBM A2111 (-3.6A)None | 1.48A | 1xosA-1sojA:41.8 | 1xosA-1sojA:30.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XOT_A_VDNA101_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 7 / 12 | TYR A 736HIS A 737ILE A 955SER A 974GLN A 988PHE A 991ILE A 995 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A)IBM A2111 (-4.2A)NoneIBM A2111 (-3.3A)IBM A2111 (-3.6A)None | 0.67A | 1xotA-1sojA:41.8 | 1xotA-1sojA:30.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XOT_B_VDNB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 6 / 12 | TYR A 736HIS A 737ILE A 955SER A 974GLN A 988PHE A 991 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A)IBM A2111 (-4.2A)NoneIBM A2111 (-3.3A)IBM A2111 (-3.6A) | 0.51A | 1xotB-1sojA:41.9 | 1xotB-1sojA:30.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1Y4L_B_SVRB301_1 (PHOSPHOLIPASE A2HOMOLOG 2) |
4mes | THIAMINE TRANSPORTERTHIT (Lactococcuslactis) | 5 / 12 | LEU A 10GLY A 59GLY A 56LEU A 53GLY A 96 | PG4 A 211 (-4.4A)NoneNoneNoneNone | 1.03A | 1y4lA-4mesA:undetectable | 1y4lA-4mesA:17.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA4_C_CTXC1383_1 (CES1 PROTEIN) |
5wiv | D(4) DOPAMINERECEPTOR, SOLUBLECYTOCHROME B562CHIMERA (Escherichiacoli;Homosapiens) | 4 / 5 | TRP A 407PRO A 409LEU A 405GLY A 401 | NonePEG A1215 ( 4.6A)OLA A1211 ( 4.6A)OLA A1211 (-3.6A) | 1.46A | 1ya4C-5wivA:0.9 | 1ya4C-5wivA:22.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2AA5_B_STRB302_1 (MINERALOCORTICOIDRECEPTOR) |
3edi | TOLLOID-LIKE PROTEIN1 (Homosapiens) | 5 / 12 | LEU A 193MET A 147SER A 145LEU A 182THR A 3 | NoneNone ZN A 211 ( 4.6A)NoneNone | 1.39A | 2aa5B-3ediA:undetectable | 2aa5B-3ediA:21.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2AYL_A_FLPA1701_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
4hc6 | HOLO-[ACYL-CARRIER-PROTEIN] SYNTHASE (Mycobacteriumtuberculosis) | 5 / 12 | LEU A 105LEU A 75GLY A 5ALA A 63SER A 67 | None BR A 211 ( 4.6A)NoneNoneNone | 1.12A | 2aylA-4hc6A:undetectable | 2aylA-4hc6A:14.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2BDM_A_TMIA501_1 (CYTOCHROME P450 2B4) |
3pas | TETR FAMILYTRANSCRIPTIONREGULATOR (Marinobacterhydrocarbonoclasticus) | 4 / 7 | LEU A 101PHE A 102THR A 109ILE A 118 | NoneNoneACT A 211 ( 4.3A)None | 0.82A | 2bdmA-3pasA:undetectable | 2bdmA-3pasA:18.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2DYR_C_CHDC525_0 (CYTOCHROME C OXIDASESUBUNIT 1CYTOCHROME C OXIDASESUBUNIT 3) |
3kky | SUPEROXIDE DISMUTASE[MN] (Deinococcusradiodurans) | 4 / 7 | HIS A 26ASP A 12TYR A 9HIS A 30 | MN A 211 (-3.3A)NoneNoneNone | 1.49A | 2dyrA-3kkyA:1.52dyrC-3kkyA:undetectable | 2dyrA-3kkyA:17.322dyrC-3kkyA:19.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2DYR_P_CHDP1525_0 (CYTOCHROME C OXIDASESUBUNIT 1CYTOCHROME C OXIDASESUBUNIT 3) |
3kky | SUPEROXIDE DISMUTASE[MN] (Deinococcusradiodurans) | 4 / 7 | HIS A 26ASP A 12TYR A 9HIS A 30 | MN A 211 (-3.3A)NoneNoneNone | 1.49A | 2dyrN-3kkyA:undetectable2dyrP-3kkyA:undetectable | 2dyrN-3kkyA:17.322dyrP-3kkyA:19.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2DYS_C_CHDC304_0 (CYTOCHROME C OXIDASESUBUNIT 1CYTOCHROME C OXIDASESUBUNIT 3) |
3kky | SUPEROXIDE DISMUTASE[MN] (Deinococcusradiodurans) | 4 / 6 | HIS A 26ASP A 12TYR A 9HIS A 30 | MN A 211 (-3.3A)NoneNoneNone | 1.48A | 2dysA-3kkyA:1.72dysC-3kkyA:undetectable | 2dysA-3kkyA:17.322dysC-3kkyA:19.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2DYS_P_CHDP304_0 (CYTOCHROME C OXIDASESUBUNIT 1CYTOCHROME C OXIDASESUBUNIT 3) |
3kky | SUPEROXIDE DISMUTASE[MN] (Deinococcusradiodurans) | 4 / 6 | HIS A 26ASP A 12TYR A 9HIS A 30 | MN A 211 (-3.3A)NoneNoneNone | 1.46A | 2dysN-3kkyA:undetectable2dysP-3kkyA:undetectable | 2dysN-3kkyA:17.322dysP-3kkyA:19.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2EIJ_C_CHDC525_0 (CYTOCHROME C OXIDASESUBUNIT 1CYTOCHROME C OXIDASESUBUNIT 3) |
3kky | SUPEROXIDE DISMUTASE[MN] (Deinococcusradiodurans) | 4 / 7 | HIS A 26ASP A 12TYR A 9HIS A 30 | MN A 211 (-3.3A)NoneNoneNone | 1.48A | 2eijA-3kkyA:undetectable2eijC-3kkyA:undetectable | 2eijA-3kkyA:17.322eijC-3kkyA:19.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2EIJ_P_CHDP1525_0 (CYTOCHROME C OXIDASESUBUNIT 1CYTOCHROME C OXIDASESUBUNIT 3) |
3kky | SUPEROXIDE DISMUTASE[MN] (Deinococcusradiodurans) | 4 / 7 | HIS A 26ASP A 12TYR A 9HIS A 30 | MN A 211 (-3.3A)NoneNoneNone | 1.49A | 2eijN-3kkyA:undetectable2eijP-3kkyA:undetectable | 2eijN-3kkyA:17.322eijP-3kkyA:19.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2EIK_C_CHDC525_0 (CYTOCHROME C OXIDASESUBUNIT 1CYTOCHROME C OXIDASESUBUNIT 3) |
3kky | SUPEROXIDE DISMUTASE[MN] (Deinococcusradiodurans) | 4 / 7 | HIS A 26ASP A 12TYR A 9HIS A 30 | MN A 211 (-3.3A)NoneNoneNone | 1.49A | 2eikA-3kkyA:undetectable2eikC-3kkyA:undetectable | 2eikA-3kkyA:17.322eikC-3kkyA:19.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2EIK_P_CHDP1525_0 (CYTOCHROME C OXIDASESUBUNIT 1CYTOCHROME C OXIDASESUBUNIT 3) |
3kky | SUPEROXIDE DISMUTASE[MN] (Deinococcusradiodurans) | 4 / 7 | HIS A 26ASP A 12TYR A 9HIS A 30 | MN A 211 (-3.3A)NoneNoneNone | 1.49A | 2eikN-3kkyA:1.52eikP-3kkyA:undetectable | 2eikN-3kkyA:17.322eikP-3kkyA:19.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2EIL_P_CHDP1525_0 (CYTOCHROME C OXIDASESUBUNIT 1CYTOCHROME C OXIDASESUBUNIT 3) |
3kky | SUPEROXIDE DISMUTASE[MN] (Deinococcusradiodurans) | 4 / 7 | HIS A 26ASP A 12TYR A 9HIS A 30 | MN A 211 (-3.3A)NoneNoneNone | 1.49A | 2eilN-3kkyA:undetectable2eilP-3kkyA:undetectable | 2eilN-3kkyA:17.322eilP-3kkyA:19.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2EIM_A_CHDA525_0 (CYTOCHROME C OXIDASESUBUNIT 1CYTOCHROME C OXIDASESUBUNIT 3) |
3kky | SUPEROXIDE DISMUTASE[MN] (Deinococcusradiodurans) | 4 / 6 | HIS A 26ASP A 12TYR A 9HIS A 30 | MN A 211 (-3.3A)NoneNoneNone | 1.45A | 2eimA-3kkyA:undetectable2eimC-3kkyA:undetectable | 2eimA-3kkyA:17.322eimC-3kkyA:19.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2EIN_C_CHDC525_0 (CYTOCHROME C OXIDASESUBUNIT 1CYTOCHROME C OXIDASESUBUNIT 3) |
3kky | SUPEROXIDE DISMUTASE[MN] (Deinococcusradiodurans) | 4 / 6 | HIS A 26ASP A 12TYR A 9HIS A 30 | MN A 211 (-3.3A)NoneNoneNone | 1.48A | 2einA-3kkyA:undetectable2einC-3kkyA:undetectable | 2einA-3kkyA:17.322einC-3kkyA:19.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2EJT_A_SAMA501_1 (N(2),N(2)-DIMETHYLGUANOSINE TRNAMETHYLTRANSFERASE) |
3o8s | ADP-RIBOSEPYROPHOSPHATASE (Streptococcussuis) | 3 / 3 | ARG A 125ASP A 80ASP A 173 | ACT A 211 (-3.4A)NoneNone | 0.85A | 2ejtA-3o8sA:undetectable | 2ejtA-3o8sA:19.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2G6H_A_H4BA760_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
3rq0 | GLYCOSYL HYDROLASESFAMILY PROTEIN 16 (Mycolicibacteriumsmegmatis) | 4 / 8 | VAL A 184TRP A 156TRP A 138GLU A 155 | None211 A 280 ( 4.7A)GOL A 278 (-3.7A)GOL A 278 (-3.4A) | 1.14A | 2g6hA-3rq0A:undetectable2g6hB-3rq0A:undetectable | 2g6hA-3rq0A:20.872g6hB-3rq0A:20.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2H42_A_VIAA901_1 (CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 5 / 11 | TYR A 736HIS A 737PHE A 959GLN A 988PHE A 991 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A)NoneIBM A2111 (-3.3A)IBM A2111 (-3.6A) | 0.37A | 2h42A-1sojA:34.3 | 2h42A-1sojA:24.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2H42_C_VIAC903_1 (CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 5 / 12 | TYR A 736LEU A 895PHE A 959GLN A 988PHE A 991 | IBM A2111 (-4.5A)NoneNoneIBM A2111 (-3.3A)IBM A2111 (-3.6A) | 0.41A | 2h42C-1sojA:34.1 | 2h42C-1sojA:24.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2IZQ_A_DVAA6_0 (GRAMICIDIN D) |
2btd | PTS-DEPENDENTDIHYDROXYACETONEKINASE (Escherichiacoli) | 3 / 3 | ALA A 123VAL A 117TRP A 134 | ADP A1211 ( 4.4A)NoneNone | 0.91A | 2izqA-2btdA:undetectable2izqB-2btdA:undetectable | 2izqA-2btdA:7.522izqB-2btdA:7.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2IZQ_D_DVAD6_0 (GRAMICIDIN D) |
2btd | PTS-DEPENDENTDIHYDROXYACETONEKINASE (Escherichiacoli) | 3 / 3 | TRP A 134ALA A 123VAL A 117 | NoneADP A1211 ( 4.4A)None | 0.96A | 2izqC-2btdA:undetectable2izqD-2btdA:undetectable | 2izqC-2btdA:7.522izqD-2btdA:7.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Q0J_A_BEZA500_0 (QUINOLONE SIGNALRESPONSE PROTEIN) |
2xf4 | HYDROXYACYLGLUTATHIONE HYDROLASE (Salmonellaenterica) | 5 / 10 | ASP A 60HIS A 132ASP A 151PHE A 163HIS A 192 | ZN A1211 ( 2.8A)None ZN A1211 (-2.4A)PG4 A1212 (-4.6A) ZN A1211 (-3.3A) | 0.83A | 2q0jA-2xf4A:18.4 | 2q0jA-2xf4A:24.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Q0J_B_BEZB500_0 (QUINOLONE SIGNALRESPONSE PROTEIN) |
2xf4 | HYDROXYACYLGLUTATHIONE HYDROLASE (Salmonellaenterica) | 6 / 11 | ASP A 60HIS A 61HIS A 132ASP A 151PHE A 163HIS A 192 | ZN A1211 ( 2.8A) ZN A1211 (-3.3A)None ZN A1211 (-2.4A)PG4 A1212 (-4.6A) ZN A1211 (-3.3A) | 0.87A | 2q0jB-2xf4A:18.5 | 2q0jB-2xf4A:24.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Q63_A_1UNA1001_2 (PROTEASE RETROPEPSIN) |
2yof | THYMIDYLATE KINASE (Plasmodiumfalciparum) | 3 / 3 | ARG A 99ASN A 113THR A 158 | 74W A 211 (-4.0A)NoneNone | 0.67A | 2q63A-2yofA:undetectable | 2q63A-2yofA:14.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2WEK_B_DIFB1376_1 (ZINC-BINDING ALCOHOLDEHYDROGENASEDOMAIN-CONTAININGPROTEIN 2) |
2btd | PTS-DEPENDENTDIHYDROXYACETONEKINASE (Escherichiacoli) | 4 / 7 | VAL A 76GLY A 78ALA A 79LEU A 83 | NoneADP A1211 (-3.5A)ADP A1211 (-3.5A)ADP A1211 (-4.5A) | 0.90A | 2wekB-2btdA:undetectable | 2wekB-2btdA:22.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2WEY_A_EV1A1771_1 (CAMP ANDCAMP-INHIBITED CGMP3', 5'-CYCLICPHOSPHODIESTERASE) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 8 / 12 | TYR A 736HIS A 737LEU A 895ILE A 955GLU A 958PHE A 959GLN A 988PHE A 991 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A)NoneIBM A2111 (-4.2A)NoneNoneIBM A2111 (-3.3A)IBM A2111 (-3.6A) | 0.59A | 2weyA-1sojA:36.5 | 2weyA-1sojA:24.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2WEY_B_EV1B1771_1 (CAMP ANDCAMP-INHIBITED CGMP3', 5'-CYCLICPHOSPHODIESTERASE) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 5 / 8 | LEU A 895ILE A 955PHE A 959GLN A 988PHE A 991 | NoneIBM A2111 (-4.2A)NoneIBM A2111 (-3.3A)IBM A2111 (-3.6A) | 0.35A | 2weyB-1sojA:36.2 | 2weyB-1sojA:24.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XAD_E_GCSE710_1 (N-ACYL GLMPEUDO-TEICOPLANINDEACETYLASETEICOPLANIN) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 4 / 8 | HIS A 821ASP A 937ILE A 938HIS A 741 | MG A2123 (-3.1A) MG A2123 (-2.5A)IBM A2111 (-4.1A) MG A2123 (-3.0A) | 1.05A | 2xadA-1sojA:undetectable | 2xadA-1sojA:22.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XAD_F_GCSF710_1 (N-ACYL GLMPEUDO-TEICOPLANINDEACETYLASETEICOPLANIN) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 4 / 8 | HIS A 821ASP A 937ILE A 938HIS A 741 | MG A2123 (-3.1A) MG A2123 (-2.5A)IBM A2111 (-4.1A) MG A2123 (-3.0A) | 1.09A | 2xadB-1sojA:undetectable | 2xadB-1sojA:22.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XAD_G_GCSG710_1 (N-ACYL GLMPEUDO-TEICOPLANINDEACETYLASETEICOPLANIN) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 4 / 8 | HIS A 821ASP A 937ILE A 938HIS A 741 | MG A2123 (-3.1A) MG A2123 (-2.5A)IBM A2111 (-4.1A) MG A2123 (-3.0A) | 1.07A | 2xadC-1sojA:undetectable | 2xadC-1sojA:22.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XAD_H_GCSH710_1 (N-ACYL GLMPEUDO-TEICOPLANINDEACETYLASETEICOPLANIN) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 4 / 8 | HIS A 821ASP A 937ILE A 938HIS A 741 | MG A2123 (-3.1A) MG A2123 (-2.5A)IBM A2111 (-4.1A) MG A2123 (-3.0A) | 1.07A | 2xadD-1sojA:undetectable | 2xadD-1sojA:22.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y69_A_CHDA1517_0 (CYTOCHROME C OXIDASESUBUNIT 1CYTOCHROME C OXIDASESUBUNIT 3) |
3kky | SUPEROXIDE DISMUTASE[MN] (Deinococcusradiodurans) | 4 / 7 | HIS A 26ASP A 12TYR A 9HIS A 30 | MN A 211 (-3.3A)NoneNoneNone | 1.49A | 2y69A-3kkyA:undetectable2y69C-3kkyA:undetectable | 2y69A-3kkyA:17.322y69C-3kkyA:19.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZW9_B_SAMB801_1 (LEUCINE CARBOXYLMETHYLTRANSFERASE 2) |
4cyv | HEMAGGLUTININ (InfluenzaAvirus) | 4 / 8 | ILE B 152ASN B 154TYR B 157SER B 147 | NoneNAG B 211 (-1.9A)NoneNone | 1.11A | 2zw9B-4cyvB:undetectable | 2zw9B-4cyvB:13.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZXW_C_CHDC525_0 (CYTOCHROME C OXIDASESUBUNIT 1CYTOCHROME C OXIDASESUBUNIT 3) |
3kky | SUPEROXIDE DISMUTASE[MN] (Deinococcusradiodurans) | 4 / 6 | HIS A 26ASP A 12TYR A 9HIS A 30 | MN A 211 (-3.3A)NoneNoneNone | 1.48A | 2zxwA-3kkyA:undetectable2zxwC-3kkyA:undetectable | 2zxwA-3kkyA:17.322zxwC-3kkyA:19.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZXW_P_CHDP1525_0 (CYTOCHROME C OXIDASESUBUNIT 1CYTOCHROME C OXIDASESUBUNIT 3) |
3kky | SUPEROXIDE DISMUTASE[MN] (Deinococcusradiodurans) | 4 / 6 | HIS A 26ASP A 12TYR A 9HIS A 30 | MN A 211 (-3.3A)NoneNoneNone | 1.48A | 2zxwN-3kkyA:undetectable2zxwP-3kkyA:undetectable | 2zxwN-3kkyA:17.322zxwP-3kkyA:19.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3A25_A_SAMA279_0 (UNCHARACTERIZEDPROTEIN PH0793) |
5u09 | CANNABINOID RECEPTOR1,GLGA GLYCOGENSYNTHASE (Homosapiens;Pyrococcusabyssi) | 5 / 12 | ASN A 187ARG A 186HIS A 270ILE A 267ASP A 104 | SO4 A1211 (-4.5A)NoneNoneNoneNone | 1.43A | 3a25A-5u09A:4.0 | 3a25A-5u09A:21.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ABK_P_CHDP1525_0 (CYTOCHROME C OXIDASESUBUNIT 1CYTOCHROME C OXIDASESUBUNIT 3) |
3kky | SUPEROXIDE DISMUTASE[MN] (Deinococcusradiodurans) | 4 / 7 | HIS A 26ASP A 12TYR A 9HIS A 30 | MN A 211 (-3.3A)NoneNoneNone | 1.47A | 3abkN-3kkyA:undetectable3abkP-3kkyA:undetectable | 3abkN-3kkyA:17.323abkP-3kkyA:19.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ABM_P_CHDP1525_0 (CYTOCHROME C OXIDASESUBUNIT 1CYTOCHROME C OXIDASESUBUNIT 3) |
3kky | SUPEROXIDE DISMUTASE[MN] (Deinococcusradiodurans) | 4 / 7 | HIS A 26ASP A 12TYR A 9HIS A 30 | MN A 211 (-3.3A)NoneNoneNone | 1.48A | 3abmN-3kkyA:undetectable3abmP-3kkyA:undetectable | 3abmN-3kkyA:17.323abmP-3kkyA:19.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3AG1_P_CHDP1525_0 (CYTOCHROME C OXIDASESUBUNIT 1CYTOCHROME C OXIDASESUBUNIT 3) |
3kky | SUPEROXIDE DISMUTASE[MN] (Deinococcusradiodurans) | 4 / 6 | HIS A 26ASP A 12TYR A 9HIS A 30 | MN A 211 (-3.3A)NoneNoneNone | 1.50A | 3ag1N-3kkyA:undetectable3ag1P-3kkyA:undetectable | 3ag1N-3kkyA:17.323ag1P-3kkyA:19.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3AG2_A_CHDA525_0 (CYTOCHROME C OXIDASESUBUNIT 1CYTOCHROME C OXIDASESUBUNIT 3) |
3kky | SUPEROXIDE DISMUTASE[MN] (Deinococcusradiodurans) | 4 / 7 | HIS A 26ASP A 12TYR A 9HIS A 30 | MN A 211 (-3.3A)NoneNoneNone | 1.49A | 3ag2A-3kkyA:undetectable3ag2C-3kkyA:undetectable | 3ag2A-3kkyA:17.323ag2C-3kkyA:19.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3AG2_P_CHDP1525_0 (CYTOCHROME C OXIDASESUBUNIT 1CYTOCHROME C OXIDASESUBUNIT 3) |
3kky | SUPEROXIDE DISMUTASE[MN] (Deinococcusradiodurans) | 4 / 7 | HIS A 26ASP A 12TYR A 9HIS A 30 | MN A 211 (-3.3A)NoneNoneNone | 1.49A | 3ag2N-3kkyA:undetectable3ag2P-3kkyA:undetectable | 3ag2N-3kkyA:17.323ag2P-3kkyA:19.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3AG3_C_CHDC525_0 (CYTOCHROME C OXIDASESUBUNIT 1CYTOCHROME C OXIDASESUBUNIT 3) |
3kky | SUPEROXIDE DISMUTASE[MN] (Deinococcusradiodurans) | 4 / 7 | HIS A 26ASP A 12TYR A 9HIS A 30 | MN A 211 (-3.3A)NoneNoneNone | 1.48A | 3ag3A-3kkyA:undetectable3ag3C-3kkyA:undetectable | 3ag3A-3kkyA:17.323ag3C-3kkyA:19.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3AG3_P_CHDP1525_0 (CYTOCHROME C OXIDASESUBUNIT 1CYTOCHROME C OXIDASESUBUNIT 3) |
3kky | SUPEROXIDE DISMUTASE[MN] (Deinococcusradiodurans) | 4 / 7 | HIS A 26ASP A 12TYR A 9HIS A 30 | MN A 211 (-3.3A)NoneNoneNone | 1.49A | 3ag3N-3kkyA:1.83ag3P-3kkyA:undetectable | 3ag3N-3kkyA:17.323ag3P-3kkyA:19.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3AG4_C_CHDC525_0 (CYTOCHROME C OXIDASESUBUNIT 1CYTOCHROME C OXIDASESUBUNIT 3) |
3kky | SUPEROXIDE DISMUTASE[MN] (Deinococcusradiodurans) | 4 / 7 | HIS A 26ASP A 12TYR A 9HIS A 30 | MN A 211 (-3.3A)NoneNoneNone | 1.48A | 3ag4A-3kkyA:undetectable3ag4C-3kkyA:undetectable | 3ag4A-3kkyA:17.323ag4C-3kkyA:19.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3AG4_P_CHDP1525_0 (CYTOCHROME C OXIDASESUBUNIT 1CYTOCHROME C OXIDASESUBUNIT 3) |
3kky | SUPEROXIDE DISMUTASE[MN] (Deinococcusradiodurans) | 4 / 7 | HIS A 26ASP A 12TYR A 9HIS A 30 | MN A 211 (-3.3A)NoneNoneNone | 1.49A | 3ag4N-3kkyA:undetectable3ag4P-3kkyA:undetectable | 3ag4N-3kkyA:17.323ag4P-3kkyA:19.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3AOD_A_MIYA2001_1 (ACRIFLAVINERESISTANCE PROTEIN B) |
2xcm | CYTOSOLIC HEAT SHOCKPROTEIN 90 (Hordeumvulgare) | 4 / 8 | GLY A 172ASN A 143ILE A 47ALA A 43 | NoneNoneNoneADP A1211 (-3.2A) | 0.97A | 3aodA-2xcmA:undetectable | 3aodA-2xcmA:11.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3APV_B_TP0B190_1 (ALPHA-1-ACIDGLYCOPROTEIN 2) |
2yof | THYMIDYLATE KINASE (Plasmodiumfalciparum) | 5 / 12 | LEU A 59GLU A 151ARG A 47SER A 103TYR A 107 | 74W A 211 (-4.6A)74W A 211 (-3.2A)74W A 211 (-4.6A)74W A 211 ( 4.4A)74W A 211 (-3.5A) | 1.41A | 3apvB-2yofA:undetectable | 3apvB-2yofA:20.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ASN_C_CHDC525_0 (CYTOCHROME C OXIDASESUBUNIT 1CYTOCHROME C OXIDASESUBUNIT 3) |
3kky | SUPEROXIDE DISMUTASE[MN] (Deinococcusradiodurans) | 4 / 6 | HIS A 26ASP A 12TYR A 9HIS A 30 | MN A 211 (-3.3A)NoneNoneNone | 1.50A | 3asnA-3kkyA:1.73asnC-3kkyA:undetectable | 3asnA-3kkyA:17.323asnC-3kkyA:19.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3B2R_A_VDNA1_1 (CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 5 / 12 | TYR A 736HIS A 737PHE A 959GLN A 988PHE A 991 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A)NoneIBM A2111 (-3.3A)IBM A2111 (-3.6A) | 0.50A | 3b2rA-1sojA:30.1 | 3b2rA-1sojA:24.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3B3P_B_H4BB760_1 (NITRIC-OXIDESYNTHASE) |
3rq0 | GLYCOSYL HYDROLASESFAMILY PROTEIN 16 (Mycolicibacteriumsmegmatis) | 4 / 8 | TRP A 138GLU A 155VAL A 184TRP A 156 | GOL A 278 (-3.7A)GOL A 278 (-3.4A)None211 A 280 ( 4.7A) | 0.98A | 3b3pA-3rq0A:undetectable3b3pB-3rq0A:undetectable | 3b3pA-3rq0A:20.783b3pB-3rq0A:20.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3BJW_B_SVRB512_2 (PHOSPHOLIPASE A2) |
5wzm | GROUP IIE SECRETORYPHOSPHOLIPASE A2 (Homosapiens) | 4 / 7 | VAL A 3GLY A 14ARG A 98LEU A 101 | NoneNoneNoneTRS A 211 (-4.0A) | 0.53A | 3bjwB-5wzmA:20.3 | 3bjwB-5wzmA:29.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3BJW_E_SVRE510_2 (PHOSPHOLIPASE A2) |
5wzm | GROUP IIE SECRETORYPHOSPHOLIPASE A2 (Homosapiens) | 4 / 6 | VAL A 3GLY A 14ARG A 98LEU A 101 | NoneNoneNoneTRS A 211 (-4.0A) | 0.54A | 3bjwE-5wzmA:20.0 | 3bjwE-5wzmA:29.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3BJW_F_SVRF509_3 (PHOSPHOLIPASE A2) |
5wzm | GROUP IIE SECRETORYPHOSPHOLIPASE A2 (Homosapiens) | 4 / 7 | VAL A 3GLY A 14ARG A 98LEU A 101 | NoneNoneNoneTRS A 211 (-4.0A) | 0.52A | 3bjwF-5wzmA:20.5 | 3bjwF-5wzmA:29.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3BJW_H_SVRH511_3 (PHOSPHOLIPASE A2) |
5wzm | GROUP IIE SECRETORYPHOSPHOLIPASE A2 (Homosapiens) | 4 / 7 | VAL A 3GLY A 14ARG A 98LEU A 101 | NoneNoneNoneTRS A 211 (-4.0A) | 0.52A | 3bjwH-5wzmA:20.3 | 3bjwH-5wzmA:29.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3CR5_X_PNTX94_0 (PROTEIN S100-B) |
2yof | THYMIDYLATE KINASE (Plasmodiumfalciparum) | 3 / 3 | PHE A 44CYH A 97PHE A 10 | ACT A1211 (-4.2A)NoneNone | 0.71A | 3cr5X-2yofA:undetectable | 3cr5X-2yofA:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3CZV_A_AZMA263_1 (CARBONIC ANHYDRASE13) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 5 / 12 | HIS A 741HIS A 821PHE A 991THR A 893VAL A 996 | MG A2123 (-3.0A) MG A2123 (-3.1A)IBM A2111 (-3.6A)NoneNone | 1.23A | 3czvA-1sojA:undetectable3czvB-1sojA:undetectable | 3czvA-1sojA:21.653czvB-1sojA:21.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3E00_A_9CRA7223_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) |
5xxu | RIBOSOMAL PROTEINUS10RIBOSOMAL PROTEINUS14RIBOSOMAL PROTEINUS3 (Toxoplasmagondii) | 5 / 12 | ALA D 21GLN D 20ASN d 46VAL d 29ILE U 177 | NoneNoneNone G 21194 ( 4.4A)None | 1.02A | 3e00A-5xxuD:undetectable | 3e00A-5xxuD:19.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3EEY_C_SAMC300_0 (PUTATIVE RRNAMETHYLASE) |
1t6p | PHENYLALANINEAMMONIA-LYASE (Rhodotorulatoruloides) | 5 / 12 | GLY A 271ASN A 270ILE A 171GLY A 167THR A 280 | 175 A 211 ( 4.6A)175 A 211 ( 4.0A)NoneNoneNone | 1.15A | 3eeyC-1t6pA:undetectable | 3eeyC-1t6pA:14.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3EEY_E_SAME300_0 (PUTATIVE RRNAMETHYLASE) |
1t6p | PHENYLALANINEAMMONIA-LYASE (Rhodotorulatoruloides) | 5 / 12 | GLY A 271ASN A 270ILE A 171GLY A 167THR A 280 | 175 A 211 ( 4.6A)175 A 211 ( 4.0A)NoneNoneNone | 1.15A | 3eeyE-1t6pA:undetectable | 3eeyE-1t6pA:14.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G4L_A_ROFA901_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 5 / 12 | TYR A 736HIS A 737PRO A 941SER A 990PHE A 991 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A)NoneNoneIBM A2111 (-3.6A) | 1.25A | 3g4lA-1sojA:42.0 | 3g4lA-1sojA:32.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G4L_A_ROFA901_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 7 / 12 | TYR A 736HIS A 737PRO A 941TRP A 951THR A 952ILE A 955PHE A 991 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A)NoneNoneIBM A2111 ( 4.8A)IBM A2111 (-4.2A)IBM A2111 (-3.6A) | 0.53A | 3g4lA-1sojA:42.0 | 3g4lA-1sojA:32.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G4L_B_ROFB902_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 8 / 12 | TYR A 736HIS A 737ASP A 937PRO A 941TRP A 951THR A 952ILE A 955PHE A 991 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A) MG A2123 (-2.5A)NoneNoneIBM A2111 ( 4.8A)IBM A2111 (-4.2A)IBM A2111 (-3.6A) | 0.48A | 3g4lB-1sojA:41.7 | 3g4lB-1sojA:32.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G4L_C_ROFC903_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 7 / 12 | TYR A 736HIS A 737ASP A 937PRO A 941TRP A 951THR A 952ILE A 955 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A) MG A2123 (-2.5A)NoneNoneIBM A2111 ( 4.8A)IBM A2111 (-4.2A) | 0.49A | 3g4lC-1sojA:41.6 | 3g4lC-1sojA:32.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G4L_D_ROFD904_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 8 / 12 | TYR A 736HIS A 737ASP A 937PRO A 941TRP A 951THR A 952ILE A 955GLN A 988 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A) MG A2123 (-2.5A)NoneNoneIBM A2111 ( 4.8A)IBM A2111 (-4.2A)IBM A2111 (-3.3A) | 0.51A | 3g4lD-1sojA:41.3 | 3g4lD-1sojA:32.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HII_A_PNTA901_0 (AMILORIDE-SENSITIVEAMINE OXIDASE) |
2btd | PTS-DEPENDENTDIHYDROXYACETONEKINASE (Escherichiacoli) | 5 / 12 | THR A 195ASP A 191ASP A 37GLY A 78VAL A 76 | NoneADP A1211 (-2.5A)ADP A1211 (-2.5A)ADP A1211 (-3.5A)None | 1.38A | 3hiiA-2btdA:0.0 | 3hiiA-2btdA:14.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HII_B_PNTB901_0 (AMILORIDE-SENSITIVEAMINE OXIDASE) |
2btd | PTS-DEPENDENTDIHYDROXYACETONEKINASE (Escherichiacoli) | 5 / 12 | THR A 195ASP A 191ASP A 37GLY A 78VAL A 76 | NoneADP A1211 (-2.5A)ADP A1211 (-2.5A)ADP A1211 (-3.5A)None | 1.38A | 3hiiB-2btdA:0.0 | 3hiiB-2btdA:14.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HP1_A_LLTA401_1 (DEOXYCYTIDINE KINASE) |
4unr | THYMIDYLATE KINASE (Mycobacteriumtuberculosis) | 5 / 12 | GLU A 124VAL A 120TYR A 179GLN A 136ARG A 74 | NoneNoneNoneNoneQZE A1211 (-2.7A) | 1.32A | 3hp1A-4unrA:12.7 | 3hp1A-4unrA:19.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HS4_A_AZMA702_1 (CARBONIC ANHYDRASE 2) |
5ezt | CARBONIC ANHYDRASE 2 (Bostaurus) | 4 / 7 | VAL X 108TYR X 113TRP X 190PRO X 213 | ALY X 111 ( 4.6A)ALY X 111 ( 3.6A)ALY X 211 ( 3.8A)ALY X 147 ( 3.8A) | 0.31A | 3hs4A-5eztX:44.6 | 3hs4A-5eztX:80.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3IAK_A_EV1A415_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 6 / 9 | TYR A 736ILE A 955PHE A 959GLN A 988PHE A 991ILE A 995 | IBM A2111 (-4.5A)IBM A2111 (-4.2A)NoneIBM A2111 (-3.3A)IBM A2111 (-3.6A)None | 0.58A | 3iakA-1sojA:42.0 | 3iakA-1sojA:31.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JUS_B_ECLB600_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
2x3l | ORN/LYS/ARGDECARBOXYLASE FAMILYPROTEIN (Staphylococcusaureus) | 5 / 8 | THR A 197GLY A 185ALA A 183THR A 81ILE A 85 | NoneNonePLP A1211 (-3.4A)PLP A1211 (-3.8A)None | 1.25A | 3jusB-2x3lA:undetectable | 3jusB-2x3lA:23.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JUS_B_ECNB602_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
2x3l | ORN/LYS/ARGDECARBOXYLASE FAMILYPROTEIN (Staphylococcusaureus) | 5 / 9 | THR A 197GLY A 185ALA A 183THR A 81ILE A 85 | NoneNonePLP A1211 (-3.4A)PLP A1211 (-3.8A)None | 1.25A | 3jusB-2x3lA:undetectable | 3jusB-2x3lA:23.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JWQ_A_VIAA901_1 (CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASECATALYTIC DOMAIN,CONE CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASESUBUNIT ALPHACHIMERA) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 6 / 9 | TYR A 736HIS A 737LEU A 895LEU A 984GLN A 988PHE A 991 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A)NoneNoneIBM A2111 (-3.3A)IBM A2111 (-3.6A) | 0.52A | 3jwqA-1sojA:37.4 | 3jwqA-1sojA:24.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JWQ_B_VIAB901_1 (CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASECATALYTIC DOMAIN,CONE CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASESUBUNIT ALPHACHIMERA) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 6 / 11 | TYR A 736HIS A 737LEU A 895LEU A 984GLN A 988PHE A 991 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A)NoneNoneIBM A2111 (-3.3A)IBM A2111 (-3.6A) | 0.66A | 3jwqB-1sojA:37.33jwqC-1sojA:37.3 | 3jwqB-1sojA:24.243jwqC-1sojA:24.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JWQ_C_VIAC901_1 (CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASECATALYTIC DOMAIN,CONE CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASESUBUNIT ALPHACHIMERA) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 5 / 7 | TYR A 736HIS A 737LEU A 984GLN A 988PHE A 991 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A)NoneIBM A2111 (-3.3A)IBM A2111 (-3.6A) | 0.55A | 3jwqC-1sojA:37.3 | 3jwqC-1sojA:24.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JWQ_D_VIAD901_1 (CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASECATALYTIC DOMAIN,CONE CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASESUBUNIT ALPHACHIMERA) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 5 / 11 | GLN A 962TYR A 736HIS A 737LEU A 984GLN A 988 | NoneIBM A2111 (-4.5A)IBM A2111 ( 4.8A)NoneIBM A2111 (-3.3A) | 1.47A | 3jwqA-1sojA:37.43jwqD-1sojA:37.1 | 3jwqA-1sojA:24.243jwqD-1sojA:24.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JWQ_D_VIAD901_1 (CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASECATALYTIC DOMAIN,CONE CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASESUBUNIT ALPHACHIMERA) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 6 / 11 | TYR A 736HIS A 737LEU A 895LEU A 984GLN A 988PHE A 991 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A)NoneNoneIBM A2111 (-3.3A)IBM A2111 (-3.6A) | 1.07A | 3jwqA-1sojA:37.43jwqD-1sojA:37.1 | 3jwqA-1sojA:24.243jwqD-1sojA:24.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JWQ_D_VIAD901_1 (CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASECATALYTIC DOMAIN,CONE CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASESUBUNIT ALPHACHIMERA) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 6 / 11 | TYR A 736HIS A 737LEU A 895PHE A 959GLN A 988PHE A 991 | IBM A2111 (-4.5A)IBM A2111 ( 4.8A)NoneNoneIBM A2111 (-3.3A)IBM A2111 (-3.6A) | 0.45A | 3jwqA-1sojA:37.43jwqD-1sojA:37.1 | 3jwqA-1sojA:24.243jwqD-1sojA:24.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JZ0_B_CLYB900_1 (LINCOSAMIDENUCLEOTIDYLTRANSFERASE) |
5jja | SERINE/THREONINE-PROTEIN PHOSPHATASE 2A56 KDA REGULATORYSUBUNIT GAMMAISOFORM (Homosapiens) | 4 / 8 | TYR A 263TYR A 292PHE A 211ILE A 207 | TYR A 263 ( 1.3A)TYR A 292 ( 1.3A)PHE A 211 ( 1.3A)ILE A 207 ( 0.7A) | 1.06A | 3jz0B-5jjaA:2.1 | 3jz0B-5jjaA:22.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KK6_A_CELA701_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
4hc6 | HOLO-[ACYL-CARRIER-PROTEIN] SYNTHASE (Mycobacteriumtuberculosis) | 5 / 12 | LEU A 105LEU A 75GLY A 5ALA A 63SER A 67 | None BR A 211 ( 4.6A)NoneNoneNone | 1.03A | 3kk6A-4hc6A:1.4 | 3kk6A-4hc6A:14.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KPB_C_SAMC1000_0 (UNCHARACTERIZEDPROTEIN MJ0100) |
3fhm | UNCHARACTERIZEDPROTEIN ATU1752 (Agrobacteriumfabrum) | 7 / 12 | HIS A 105ILE A 52THR A 54ASP A 57THR A 79VAL A 82PRO A 107 | NAI A 211 ( 4.0A)AMP A 200 (-4.0A)AMP A 200 (-2.9A)AMP A 200 (-2.9A)AMP A 200 (-3.5A)AMP A 200 ( 4.3A)AMP A 200 (-4.7A) | 0.80A | 3kpbC-3fhmA:16.7 | 3kpbC-3fhmA:27.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KPB_C_SAMC1000_0 (UNCHARACTERIZEDPROTEIN MJ0100) |
3fhm | UNCHARACTERIZEDPROTEIN ATU1752 (Agrobacteriumfabrum) | 5 / 12 | HIS A 105ILE A 117ASP A 122VAL A 16ILE A 37 | NAI A 211 ( 4.0A)NAI A 211 (-4.2A)NAI A 211 (-2.8A)NAI A 211 (-3.7A)NAI A 211 (-3.8A) | 0.88A | 3kpbC-3fhmA:16.7 | 3kpbC-3fhmA:27.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KPD_C_SAMC1000_1 (UNCHARACTERIZEDPROTEIN MJ0100) |
3fhm | UNCHARACTERIZEDPROTEIN ATU1752 (Agrobacteriumfabrum) | 5 / 12 | ILE A 117ASP A 122VAL A 16ILE A 37VAL A 40 | NAI A 211 (-4.2A)NAI A 211 (-2.8A)NAI A 211 (-3.7A)NAI A 211 (-3.8A)NAI A 211 ( 4.5A) | 0.58A | 3kpdC-3fhmA:17.3 | 3kpdC-3fhmA:27.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3L8L_D_DVAD6_0 (GRAMICIDIN D) |
2btd | PTS-DEPENDENTDIHYDROXYACETONEKINASE (Escherichiacoli) | 3 / 3 | TRP A 134ALA A 123VAL A 117 | NoneADP A1211 ( 4.4A)None | 1.00A | 3l8lC-2btdA:undetectable3l8lD-2btdA:undetectable | 3l8lC-2btdA:7.523l8lD-2btdA:8.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LPS_A_NOVA901_1 (TOPOISOMERASE IVSUBUNIT B) |
2xcm | CYTOSOLIC HEAT SHOCKPROTEIN 90 (Hordeumvulgare) | 5 / 12 | ASN A 39SER A 40ASP A 42ASP A 81THR A 173 | ADP A1211 ( 2.6A)ADP A1211 ( 4.0A)NoneADP A1211 (-3.5A)ADP A1211 (-3.4A) | 0.32A | 3lpsA-2xcmA:11.9 | 3lpsA-2xcmA:20.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LPS_A_NOVA901_1 (TOPOISOMERASE IVSUBUNIT B) |
2xcm | CYTOSOLIC HEAT SHOCKPROTEIN 90 (Hordeumvulgare) | 5 / 12 | SER A 40ASP A 42ASP A 81ASP A 144THR A 173 | ADP A1211 ( 4.0A)NoneADP A1211 (-3.5A)NoneADP A1211 (-3.4A) | 1.19A | 3lpsA-2xcmA:11.9 | 3lpsA-2xcmA:20.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LPS_A_NOVA901_1 (TOPOISOMERASE IVSUBUNIT B) |
2xcm | CYTOSOLIC HEAT SHOCKPROTEIN 90 (Hordeumvulgare) | 5 / 12 | SER A 40ASP A 42ASP A 81MET A 86THR A 173 | ADP A1211 ( 4.0A)NoneADP A1211 (-3.5A)ADP A1211 (-3.4A)ADP A1211 (-3.4A) | 0.69A | 3lpsA-2xcmA:11.9 | 3lpsA-2xcmA:20.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MB5_A_SAMA301_0 (SAM-DEPENDENTMETHYLTRANSFERASE) |
4g41 | MTA/SAH NUCLEOSIDASE (Streptococcuspyogenes) | 5 / 12 | ILE A 211GLY A 75SER A 76ILE A 190ILE A 71 | ILE A 211 ( 0.7A)GLY A 75 ( 0.0A)SER A 76 ( 0.0A)ILE A 190 ( 0.7A)ILE A 71 ( 0.7A) | 1.05A | 3mb5A-4g41A:undetectable | 3mb5A-4g41A:23.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NT1_A_NPSA5_1 (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 2) |
4hc6 | HOLO-[ACYL-CARRIER-PROTEIN] SYNTHASE (Mycobacteriumtuberculosis) | 5 / 12 | LEU A 105LEU A 75GLY A 5ALA A 63SER A 67 | None BR A 211 ( 4.6A)NoneNoneNone | 0.99A | 3nt1A-4hc6A:1.8 | 3nt1A-4hc6A:11.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NT1_B_NPSB4_1 (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 2) |
4hc6 | HOLO-[ACYL-CARRIER-PROTEIN] SYNTHASE (Mycobacteriumtuberculosis) | 5 / 12 | LEU A 105LEU A 75GLY A 5ALA A 63SER A 67 | None BR A 211 ( 4.6A)NoneNoneNone | 0.99A | 3nt1B-4hc6A:undetectable | 3nt1B-4hc6A:11.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P5N_A_RBFA190_1 (RIBOFLAVIN UPTAKEPROTEIN) |
5lal | DIRIGENT PROTEIN 6 (Arabidopsisthaliana) | 5 / 12 | LEU A 120THR A 119GLY A 129ALA A 158LEU A 183 | NoneNoneNoneEDO A 211 (-3.9A)None | 1.16A | 3p5nA-5lalA:undetectable | 3p5nA-5lalA:23.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P5N_B_RBFB190_1 (RIBOFLAVIN UPTAKEPROTEIN) |
5lal | DIRIGENT PROTEIN 6 (Arabidopsisthaliana) | 5 / 12 | LEU A 120THR A 119GLY A 129ALA A 158LEU A 183 | NoneNoneNoneEDO A 211 (-3.9A)None | 1.15A | 3p5nB-5lalA:undetectable | 3p5nB-5lalA:23.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P6H_A_IBPA133_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
2jcs | DEOXYNUCLEOSIDEKINASE (Drosophilamelanogaster) | 4 / 7 | ASP A 52ILE A 164VAL A 175TYR A 179 | MG A1211 ( 2.9A)NoneNoneNone | 1.08A | 3p6hA-2jcsA:undetectable | 3p6hA-2jcsA:17.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3QL6_A_NIMA614_1 (LACTOPEROXIDASE) |
2i82 | RIBOSOMAL LARGESUBUNITPSEUDOURIDINESYNTHASE A (Escherichiacoli) | 4 / 7 | GLN A 125HIS A 162ARG A 165PRO A 156 | A E1211 ( 3.7A) G E1210 ( 3.8A)NoneNone | 1.42A | 3ql6A-2i82A:undetectable | 3ql6A-2i82A:17.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3RET_A_SALA201_1 (SALICYLATEBIOSYNTHESIS PROTEINPCHB) |
2rci | TYPE-2BA CYTOLYTICDELTA-ENDOTOXIN (Bacillusthuringiensis) | 5 / 10 | ALA A 211VAL A 107MET A 110ILE A 205ILE A 193 | ALA A 211 ( 0.0A)VAL A 107 ( 0.6A)MET A 110 ( 0.0A)ILE A 205 ( 0.7A)ILE A 193 ( 0.6A) | 1.25A | 3retA-2rciA:undetectable3retB-2rciA:undetectable | 3retA-2rciA:18.273retB-2rciA:18.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3RR3_C_FLRC700_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
4hc6 | HOLO-[ACYL-CARRIER-PROTEIN] SYNTHASE (Mycobacteriumtuberculosis) | 5 / 12 | LEU A 105LEU A 75GLY A 5ALA A 63SER A 67 | None BR A 211 ( 4.6A)NoneNoneNone | 1.04A | 3rr3C-4hc6A:undetectable | 3rr3C-4hc6A:12.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3RR3_D_FLRD700_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
4hc6 | HOLO-[ACYL-CARRIER-PROTEIN] SYNTHASE (Mycobacteriumtuberculosis) | 5 / 12 | LEU A 105LEU A 75GLY A 5ALA A 63SER A 67 | None BR A 211 ( 4.6A)NoneNoneNone | 1.04A | 3rr3D-4hc6A:undetectable | 3rr3D-4hc6A:12.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3S3M_A_DLUA398_1 (PFV INTEGRASE) |
3f9k | INTEGRASE (Humanimmunodeficiencyvirus2) | 4 / 8 | ASP A 64ASP A 116GLY A 118GLN A 148 | MG A 211 (-2.6A) MG A 211 (-2.9A)NoneNone | 0.83A | 3s3mA-3f9kA:undetectable | 3s3mA-3f9kA:19.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3S3M_A_DLUA398_1 (PFV INTEGRASE) |
3f9k | INTEGRASE (Humanimmunodeficiencyvirus2) | 4 / 8 | ASP A 64ASP A 116GLY A 118GLU A 152 | MG A 211 (-2.6A) MG A 211 (-2.9A)NoneNone | 1.03A | 3s3mA-3f9kA:undetectable | 3s3mA-3f9kA:19.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3S3N_A_DLUA398_1 (PFV INTEGRASE) |
3f9k | INTEGRASE (Humanimmunodeficiencyvirus2) | 4 / 8 | ASP A 64ASP A 116GLY A 118GLN A 148 | MG A 211 (-2.6A) MG A 211 (-2.9A)NoneNone | 0.75A | 3s3nA-3f9kA:undetectable | 3s3nA-3f9kA:19.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3S3N_A_DLUA398_1 (PFV INTEGRASE) |
3f9k | INTEGRASE (Humanimmunodeficiencyvirus2) | 4 / 8 | ASP A 64ASP A 116GLY A 118GLU A 152 | MG A 211 (-2.6A) MG A 211 (-2.9A)NoneNone | 1.01A | 3s3nA-3f9kA:undetectable | 3s3nA-3f9kA:19.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TBG_A_RTZA1_1 (CYTOCHROME P450 2D6) |
5o27 | NEUROGLOBIN (Musmusculus) | 5 / 12 | LEU A 38PHE A 42GLY A 110LEU A 113PHE A 106 | HEM A 201 ( 4.7A)HEM A 201 (-3.8A)None XE A 206 ( 4.5A) XE A 211 (-4.3A) | 1.19A | 3tbgA-5o27A:undetectable | 3tbgA-5o27A:14.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TBG_B_RTZB1_1 (CYTOCHROME P450 2D6) |
4ikm | MALTOSE-BINDINGPERIPLASMIC PROTEIN,CASPASE RECRUITMENTDOMAIN-CONTAININGPROTEIN 8 (Escherichiacoli;Homosapiens) | 5 / 12 | PHE A 157GLY A 301LEU A 300GLU A 112ALA A 232 | NoneNoneTYI A 308 ( 4.9A)MAL A 501 (-2.9A)TYI A 211 ( 3.8A) | 0.83A | 3tbgB-4ikmA:undetectable | 3tbgB-4ikmA:22.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TBG_C_RTZC1_1 (CYTOCHROME P450 2D6) |
5o27 | NEUROGLOBIN (Musmusculus) | 5 / 12 | LEU A 38PHE A 42GLY A 110LEU A 113PHE A 106 | HEM A 201 ( 4.7A)HEM A 201 (-3.8A)None XE A 206 ( 4.5A) XE A 211 (-4.3A) | 1.21A | 3tbgC-5o27A:undetectable | 3tbgC-5o27A:14.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TBG_D_RTZD1_1 (CYTOCHROME P450 2D6) |
4ikm | MALTOSE-BINDINGPERIPLASMIC PROTEIN,CASPASE RECRUITMENTDOMAIN-CONTAININGPROTEIN 8 (Escherichiacoli;Homosapiens) | 5 / 12 | PHE A 157GLY A 301LEU A 300GLU A 112ALA A 232 | NoneNoneTYI A 308 ( 4.9A)MAL A 501 (-2.9A)TYI A 211 ( 3.8A) | 0.82A | 3tbgD-4ikmA:undetectable | 3tbgD-4ikmA:22.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TVX_A_PNXA902_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4A) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 6 / 9 | TYR A 736PRO A 941THR A 952ILE A 955GLN A 988PHE A 991 | IBM A2111 (-4.5A)NoneIBM A2111 ( 4.8A)IBM A2111 (-4.2A)IBM A2111 (-3.3A)IBM A2111 (-3.6A) | 0.53A | 3tvxA-1sojA:41.2 | 3tvxA-1sojA:30.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TVX_B_PNXB902_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4A) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 5 / 7 | TYR A 736ILE A 955PHE A 959GLN A 988PHE A 991 | IBM A2111 (-4.5A)IBM A2111 (-4.2A)NoneIBM A2111 (-3.3A)IBM A2111 (-3.6A) | 0.59A | 3tvxB-1sojA:41.3 | 3tvxB-1sojA:30.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4A6N_A_T1CA392_1 (TETX2 PROTEIN) |
4flx | DNA POLYMERASE 1 (Pyrococcusabyssi) | 5 / 11 | GLN A 665PHE A 152GLY A 696ALA A 215GLY A 211 | GLN A 665 ( 0.6A)PHE A 152 ( 1.3A)GLY A 696 ( 0.0A)ALA A 215 ( 0.0A)GLY A 211 ( 0.0A) | 1.24A | 4a6nA-4flxA:undetectable | 4a6nA-4flxA:20.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4A97_I_ZPCI1318_2 (CYS-LOOPLIGAND-GATED IONCHANNEL) |
2j4x | MITOGEN (Streptococcusdysgalactiae) | 4 / 6 | GLU A 191PHE A 136TYR A 171HIS A 170 | NoneNoneNone ZN A1211 (-3.1A) | 1.22A | 4a97I-2j4xA:undetectable | 4a97I-2j4xA:20.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4A97_J_ZPCJ1318_2 (CYS-LOOPLIGAND-GATED IONCHANNEL) |
2j4x | MITOGEN (Streptococcusdysgalactiae) | 4 / 5 | GLU A 191PHE A 136TYR A 171HIS A 170 | NoneNoneNone ZN A1211 (-3.1A) | 1.22A | 4a97J-2j4xA:0.0 | 4a97J-2j4xA:20.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4AN2_A_EUIA1382_2 (DUAL SPECIFICITYMITOGEN-ACTIVATEDPROTEIN KINASEKINASE 1) |
1yz4 | DUAL SPECIFICITYPHOSPHATASE-LIKE 15ISOFORM A (Homosapiens) | 4 / 4 | ASN A 83SER A 95LEU A 14THR A 32 | NoneSO4 A 211 ( 4.5A)NoneNone | 1.39A | 4an2A-1yz4A:undetectable | 4an2A-1yz4A:21.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4BLV_B_SAMB1281_0 (RIBOSOMAL RNA LARGESUBUNITMETHYLTRANSFERASE J) |
3cr3 | PTS-DEPENDENTDIHYDROXYACETONEKINASE, ADP-BINDINGSUBUNIT DHALPTS-DEPENDENTDIHYDROXYACETONEKINASE,PHOSPHOTRANSFERASESUBUNIT DHAM (Lactococcuslactis;Lactococcuslactis) | 5 / 12 | HIS C 10ASP A 36HIS A 37GLY A 33LEU A 28 | None MG A1212 (-2.5A)ADP A1211 (-4.0A)NoneNone | 0.97A | 4blvB-3cr3C:undetectable | 4blvB-3cr3C:19.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4C1D_B_X8ZB350_1 (BETA-LACTAMASE CLASSB VIM-2) |
2xf4 | HYDROXYACYLGLUTATHIONE HYDROLASE (Salmonellaenterica) | 5 / 10 | HIS A 56HIS A 58ASP A 60HIS A 132HIS A 192 | NonePG4 A1212 ( 3.7A) ZN A1211 ( 2.8A)None ZN A1211 (-3.3A) | 0.79A | 4c1dB-2xf4A:4.9 | 4c1dB-2xf4A:22.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4C1F_A_X8ZA300_1 (BETA-LACTAMASE IMP-1) |
2xf4 | HYDROXYACYLGLUTATHIONE HYDROLASE (Salmonellaenterica) | 5 / 11 | HIS A 56HIS A 58ASP A 60HIS A 132HIS A 192 | NonePG4 A1212 ( 3.7A) ZN A1211 ( 2.8A)None ZN A1211 (-3.3A) | 0.81A | 4c1fA-2xf4A:19.64c1fB-2xf4A:6.3 | 4c1fA-2xf4A:23.364c1fB-2xf4A:23.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4C1H_A_X8ZA305_1 (BETA-LACTAMASE 2) |
2xf4 | HYDROXYACYLGLUTATHIONE HYDROLASE (Salmonellaenterica) | 5 / 9 | HIS A 56HIS A 58ASP A 60HIS A 132HIS A 192 | NonePG4 A1212 ( 3.7A) ZN A1211 ( 2.8A)None ZN A1211 (-3.3A) | 0.77A | 4c1hA-2xf4A:20.2 | 4c1hA-2xf4A:22.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4C1H_A_X8ZA305_1 (BETA-LACTAMASE 2) |
2xf4 | HYDROXYACYLGLUTATHIONE HYDROLASE (Salmonellaenterica) | 5 / 9 | HIS A 58ASP A 60HIS A 56GLY A 159HIS A 192 | PG4 A1212 ( 3.7A) ZN A1211 ( 2.8A)NoneNone ZN A1211 (-3.3A) | 1.06A | 4c1hA-2xf4A:20.2 | 4c1hA-2xf4A:22.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DCM_A_SAMA401_0 (RIBOSOMAL RNA LARGESUBUNITMETHYLTRANSFERASE G) |
5x2v | L-METHIONINEGAMMA-LYASE (Pseudomonasputida) | 5 / 11 | ALA A 221ASP A 218GLY A 217GLY A 215ILE A 219 | NoneNoneNoneLLP A 211 ( 3.6A)None | 1.13A | 4dcmA-5x2vA:undetectable | 4dcmA-5x2vA:22.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DFB_B_KANB401_1 (APH(2')-ID) |
1k26 | NUDIX HOMOLOG (Pyrobaculumaerophilum) | 5 / 10 | ASP A 93SER A 5GLU A 45GLU A 49GLU A 33 | GOL A 209 (-4.2A)GOL A 209 ( 4.2A)NoneGOL A 211 (-3.7A)None | 1.19A | 4dfbB-1k26A:0.0 | 4dfbB-1k26A:19.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DX7_A_DM2A1106_1 (ACRIFLAVINERESISTANCE PROTEIN B) |
3cr3 | PTS-DEPENDENTDIHYDROXYACETONEKINASE, ADP-BINDINGSUBUNIT DHAL (Lactococcuslactis) | 5 / 11 | SER A 79MET A 90PHE A 64THR A 48ALA A 51 | ADP A1211 (-2.8A)NoneNoneNoneNone | 1.37A | 4dx7A-3cr3A:1.5 | 4dx7A-3cr3A:12.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4EQL_B_SALB602_1 (4-SUBSTITUTEDBENZOATES-GLUTAMATELIGASE GH3.12) |
3cr3 | PTS-DEPENDENTDIHYDROXYACETONEKINASE, ADP-BINDINGSUBUNIT DHALPTS-DEPENDENTDIHYDROXYACETONEKINASE,PHOSPHOTRANSFERASESUBUNIT DHAM (Lactococcuslactis) | 4 / 7 | LEU C 67ILE C 42THR C 44GLY A 77 | NoneNoneNoneADP A1211 (-3.3A) | 0.92A | 4eqlB-3cr3C:undetectable | 4eqlB-3cr3C:13.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4EXS_B_X8ZB301_1 (BETA-LACTAMASE NDM-1) |
2xf4 | HYDROXYACYLGLUTATHIONE HYDROLASE (Salmonellaenterica) | 4 / 8 | HIS A 58ASP A 60HIS A 132HIS A 192 | PG4 A1212 ( 3.7A) ZN A1211 ( 2.8A)None ZN A1211 (-3.3A) | 0.79A | 4exsB-2xf4A:18.5 | 4exsB-2xf4A:23.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4EYR_B_RITB301_1 (HIV-1 PROTEASE) |
1omo | ALANINEDEHYDROGENASE (Archaeoglobusfulgidus) | 4 / 7 | LEU A 191ALA A 215ILE A 259THR A 211 | LEU A 191 ( 0.6A)ALA A 215 ( 0.0A)ILE A 259 ( 0.6A)THR A 211 ( 0.8A) | 0.96A | 4eyrA-1omoA:undetectable | 4eyrA-1omoA:14.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4G0V_A_MIXA1301_1 (DNA TOPOISOMERASE2-BETA) |
3p9x | PHOSPHORIBOSYLGLYCINAMIDEFORMYLTRANSFERASE (Bacillushalodurans) | 4 / 7 | ILE A 108ASN A 14GLU A 174GLN A 124 | NoneSO4 A 211 (-4.0A)NoneNone | 1.12A | 4g0vA-3p9xA:2.7 | 4g0vA-3p9xA:13.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4G5J_A_0WMA1102_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) |
3j7y | UL16 (Homosapiens) | 4 / 7 | PHE N 128ILE N 131TYR N 96PRO N 153 | NoneNone A A2110 ( 4.5A)None | 1.11A | 4g5jA-3j7yN:undetectable | 4g5jA-3j7yN:21.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4GRQ_C_AVLC203_1 (MACROPHAGE MIGRATIONINHIBITORY FACTOR) |
3ghg | FIBRINOGEN GAMMACHAIN (Homosapiens) | 4 / 7 | PHE C 215TYR C 211GLN C 195PHE C 312 | PHE C 215 ( 1.3A)TYR C 211 ( 1.3A)GLN C 195 ( 0.6A)PHE C 312 ( 1.3A) | 1.39A | 4grqA-3ghgC:undetectable4grqC-3ghgC:undetectable | 4grqA-3ghgC:13.334grqC-3ghgC:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4GRQ_C_AVLC203_1 (MACROPHAGE MIGRATIONINHIBITORY FACTOR) |
3ghg | FIBRINOGEN GAMMACHAIN (Homosapiens) | 4 / 7 | PHE C 215TYR C 211TRP C 227PHE C 312 | PHE C 215 ( 1.3A)TYR C 211 ( 1.3A)TRP C 227 ( 0.5A)PHE C 312 ( 1.3A) | 1.29A | 4grqA-3ghgC:undetectable4grqC-3ghgC:undetectable | 4grqA-3ghgC:13.334grqC-3ghgC:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4HBF_A_DXCA75_0 (PPCA) |
5xyi | RIBOSOMAL PROTEINS19E, PUTATIVE (Trichomonasvaginalis) | 4 / 7 | ILE T 107LEU T 111LYS T 125GLY T 126 | NoneNone G 21177 ( 4.2A) G 21306 ( 4.3A) | 0.94A | 4hbfA-5xyiT:undetectable | 4hbfA-5xyiT:21.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4L39_A_SALA602_1 (4-SUBSTITUTEDBENZOATES-GLUTAMATELIGASE GH3.12) |
3cr3 | PTS-DEPENDENTDIHYDROXYACETONEKINASE, ADP-BINDINGSUBUNIT DHALPTS-DEPENDENTDIHYDROXYACETONEKINASE,PHOSPHOTRANSFERASESUBUNIT DHAM (Lactococcuslactis) | 4 / 6 | LEU C 67ILE C 42THR C 44GLY A 77 | NoneNoneNoneADP A1211 (-3.3A) | 0.86A | 4l39A-3cr3C:undetectable | 4l39A-3cr3C:13.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4L39_B_SALB601_1 (4-SUBSTITUTEDBENZOATES-GLUTAMATELIGASE GH3.12) |
3cr3 | PTS-DEPENDENTDIHYDROXYACETONEKINASE, ADP-BINDINGSUBUNIT DHALPTS-DEPENDENTDIHYDROXYACETONEKINASE,PHOSPHOTRANSFERASESUBUNIT DHAM (Lactococcuslactis) | 4 / 7 | LEU C 67ILE C 42THR C 44GLY A 77 | NoneNoneNoneADP A1211 (-3.3A) | 0.88A | 4l39B-3cr3C:undetectable | 4l39B-3cr3C:13.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MA8_C_Z80C301_1 (MAJOR PRION PROTEIN) |
1txu | RAB5 GDP/GTPEXCHANGE FACTOR (Homosapiens) | 4 / 5 | LEU A 146GLY A 153ILE A 211GLN A 210 | LEU A 146 ( 0.6A)GLY A 153 ( 0.0A)ILE A 211 ( 0.7A)GLN A 210 ( 0.6A) | 1.08A | 4ma8C-1txuA:2.1 | 4ma8C-1txuA:15.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4NJT_D_017D101_1 (PROTEASE) |
1omo | ALANINEDEHYDROGENASE (Archaeoglobusfulgidus) | 5 / 11 | LEU A 191ASP A 289ILE A 236THR A 211ILE A 213 | LEU A 191 ( 0.6A)ASP A 289 ( 0.6A)ILE A 236 ( 0.7A)THR A 211 ( 0.8A)ILE A 213 ( 0.7A) | 0.93A | 4njtC-1omoA:undetectable | 4njtC-1omoA:14.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OKW_A_198A1001_1 (ANDROGEN RECEPTOR) |
2vbf | BRANCHED-CHAINALPHA-KETOACIDDECARBOXYLASE (Lactococcuslactis) | 5 / 12 | LEU A 261GLY A 259THR A 237ILE A 211VAL A 209 | LEU A 261 ( 0.6A)GLY A 259 ( 0.0A)THR A 237 ( 0.8A)ILE A 211 ( 0.7A)VAL A 209 ( 0.6A) | 1.14A | 4okwA-2vbfA:undetectable | 4okwA-2vbfA:16.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QA0_A_SHHA404_2 (HISTONE DEACETYLASE8) |
5x2v | L-METHIONINEGAMMA-LYASE (Pseudomonasputida) | 3 / 3 | PRO A 159MET A 164TYR A 189 | NoneNoneLLP A 211 ( 4.6A) | 1.09A | 4qa0B-5x2vA:3.6 | 4qa0B-5x2vA:22.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QA0_B_SHHB404_1 (HISTONE DEACETYLASE8) |
5x2v | L-METHIONINEGAMMA-LYASE (Pseudomonasputida) | 3 / 3 | PRO A 159MET A 164TYR A 189 | NoneNoneLLP A 211 ( 4.6A) | 1.06A | 4qa0A-5x2vA:undetectable | 4qa0A-5x2vA:22.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QD3_A_5AEA201_1 (PEPTIDYL-TRNAHYDROLASE) |
5x5l | ADER (Acinetobacterbaumannii) | 5 / 9 | LEU A 192GLY A 234ASN A 229VAL A 207VAL A 211 | LEU A 192 ( 0.6A)GLY A 234 ( 0.0A)ASN A 229 ( 0.6A)VAL A 207 ( 0.6A)VAL A 211 ( 0.6A) | 0.98A | 4qd3A-5x5lA:undetectable | 4qd3A-5x5lA:19.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4TVT_A_ASCA301_0 (THAUMATIN-1) |
4cyf | PANTETHEINASE (Homosapiens) | 3 / 3 | THR A 236ASN A 266SER A 265 | CSO A 211 ( 4.3A)NoneNone | 0.73A | 4tvtA-4cyfA:undetectable | 4tvtA-4cyfA:16.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UCH_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3rq0 | GLYCOSYL HYDROLASESFAMILY PROTEIN 16 (Mycolicibacteriumsmegmatis) | 4 / 8 | TRP A 138GLU A 155VAL A 184TRP A 156 | GOL A 278 (-3.7A)GOL A 278 (-3.4A)None211 A 280 ( 4.7A) | 1.08A | 4uchA-3rq0A:undetectable4uchB-3rq0A:undetectable | 4uchA-3rq0A:21.264uchB-3rq0A:21.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4URN_A_NOVA2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
2xcm | CYTOSOLIC HEAT SHOCKPROTEIN 90 (Hordeumvulgare) | 5 / 11 | ASN A 39SER A 40ASP A 42ASP A 81THR A 173 | ADP A1211 ( 2.6A)ADP A1211 ( 4.0A)NoneADP A1211 (-3.5A)ADP A1211 (-3.4A) | 0.34A | 4urnA-2xcmA:11.9 | 4urnA-2xcmA:23.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4URN_A_NOVA2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
2xcm | CYTOSOLIC HEAT SHOCKPROTEIN 90 (Hordeumvulgare) | 5 / 11 | SER A 40ASP A 42ASP A 81MET A 86THR A 173 | ADP A1211 ( 4.0A)NoneADP A1211 (-3.5A)ADP A1211 (-3.4A)ADP A1211 (-3.4A) | 0.69A | 4urnA-2xcmA:11.9 | 4urnA-2xcmA:23.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4URN_B_NOVB2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
2xcm | CYTOSOLIC HEAT SHOCKPROTEIN 90 (Hordeumvulgare) | 5 / 11 | ASN A 39SER A 40ASP A 42ASP A 81THR A 173 | ADP A1211 ( 2.6A)ADP A1211 ( 4.0A)NoneADP A1211 (-3.5A)ADP A1211 (-3.4A) | 0.42A | 4urnB-2xcmA:11.3 | 4urnB-2xcmA:23.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4URN_B_NOVB2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
2xcm | CYTOSOLIC HEAT SHOCKPROTEIN 90 (Hordeumvulgare) | 5 / 11 | SER A 40ASP A 42ASP A 81MET A 86THR A 173 | ADP A1211 ( 4.0A)NoneADP A1211 (-3.5A)ADP A1211 (-3.4A)ADP A1211 (-3.4A) | 0.72A | 4urnB-2xcmA:11.3 | 4urnB-2xcmA:23.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4URN_C_NOVC2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
2xcm | CYTOSOLIC HEAT SHOCKPROTEIN 90 (Hordeumvulgare) | 5 / 11 | ASN A 39SER A 40ASP A 42ASP A 81THR A 173 | ADP A1211 ( 2.6A)ADP A1211 ( 4.0A)NoneADP A1211 (-3.5A)ADP A1211 (-3.4A) | 0.39A | 4urnC-2xcmA:11.7 | 4urnC-2xcmA:23.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4URN_C_NOVC2000_1 (DNA TOPOISOMERASEIV, B SUBUNIT) |
2xcm | CYTOSOLIC HEAT SHOCKPROTEIN 90 (Hordeumvulgare) | 5 / 11 | SER A 40ASP A 42ASP A 81MET A 86THR A 173 | ADP A1211 ( 4.0A)NoneADP A1211 (-3.5A)ADP A1211 (-3.4A)ADP A1211 (-3.4A) | 0.69A | 4urnC-2xcmA:11.7 | 4urnC-2xcmA:23.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4WG0_H_CHDH103_0 (NUCLEAR RECEPTORCOACTIVATOR 2) |
1mbx | ATP-DEPENDENT CLPPROTEASE ATP-BINDINGSUBUNIT CLP A (Escherichiacoli) | 5 / 11 | LEU A 35LEU A 31GLU A 42LEU A 44LEU A 109 | NoneNoneYBT A 211 (-2.4A)NoneNone | 1.22A | 4wg0H-1mbxA:undetectable4wg0I-1mbxA:undetectable4wg0J-1mbxA:undetectable | 4wg0H-1mbxA:8.214wg0I-1mbxA:8.214wg0J-1mbxA:8.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4WG0_M_CHDM103_0 (NUCLEAR RECEPTORCOACTIVATOR 2) |
1mbx | ATP-DEPENDENT CLPPROTEASE ATP-BINDINGSUBUNIT CLP A (Escherichiacoli) | 5 / 11 | LEU A 109GLU A 42LEU A 44LEU A 35LEU A 31 | NoneYBT A 211 (-2.4A)NoneNoneNone | 1.13A | 4wg0K-1mbxA:undetectable4wg0L-1mbxA:undetectable4wg0M-1mbxA:undetectable | 4wg0K-1mbxA:8.214wg0L-1mbxA:8.214wg0M-1mbxA:8.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XI3_C_29SC601_1 (ESTROGEN RECEPTOR) |
1yio | RESPONSE REGULATORYPROTEIN (Pseudomonasfluorescens) | 5 / 12 | ALA A 27LEU A 113LEU A 112GLY A 119LEU A 120 | NoneNoneNoneNone HG A 211 (-2.6A) | 1.06A | 4xi3C-1yioA:undetectable | 4xi3C-1yioA:21.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YMG_B_SAMB1001_0 (PUTATIVESAM-DEPENDENTO-METHYLTRANFERASE) |
3rq0 | GLYCOSYL HYDROLASESFAMILY PROTEIN 16 (Mycolicibacteriumsmegmatis) | 5 / 12 | GLY A 158TYR A 157SER A 244ALA A 137TYR A 254 | 211 A 280 (-3.5A)PG4 A 274 ( 4.7A)PG4 A 273 ( 4.6A)NoneNone | 1.06A | 4ymgB-3rq0A:undetectable | 4ymgB-3rq0A:24.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ZJL_A_ERYA1101_0 (MULTIDRUG EFFLUXPUMP SUBUNIT ACRB) |
5ep8 | PYRIMIDINE-NUCLEOSIDE PHOSPHORYLASE (Bacillussubtilis) | 5 / 12 | SER A 347GLU A 348GLU A 211THR A 202GLY A 203 | SER A 347 ( 0.0A)GLU A 348 ( 0.6A)GLU A 211 ( 0.6A)THR A 202 ( 0.8A)GLY A 203 ( 0.0A) | 1.45A | 4zjlA-5ep8A:undetectable | 4zjlA-5ep8A:18.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5A5Z_A_WJZA304_0 (BETA-LACTAMASE NDM-1) |
2xf4 | HYDROXYACYLGLUTATHIONE HYDROLASE (Salmonellaenterica) | 4 / 8 | HIS A 58ASP A 60HIS A 132HIS A 192 | PG4 A1212 ( 3.7A) ZN A1211 ( 2.8A)None ZN A1211 (-3.3A) | 0.77A | 5a5zA-2xf4A:5.0 | 5a5zA-2xf4A:22.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AYA_A_X8ZA307_1 (METALLO-BETA-LACTAMASE) |
2xf4 | HYDROXYACYLGLUTATHIONE HYDROLASE (Salmonellaenterica) | 6 / 11 | HIS A 56HIS A 58ASP A 60HIS A 61HIS A 132HIS A 192 | NonePG4 A1212 ( 3.7A) ZN A1211 ( 2.8A) ZN A1211 (-3.3A)None ZN A1211 (-3.3A) | 0.48A | 5ayaA-2xf4A:17.5 | 5ayaA-2xf4A:24.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5B1B_P_CHDP307_0 (CYTOCHROME C OXIDASESUBUNIT 1CYTOCHROME C OXIDASESUBUNIT 3) |
3kky | SUPEROXIDE DISMUTASE[MN] (Deinococcusradiodurans) | 4 / 7 | HIS A 26ASP A 12TYR A 9HIS A 30 | MN A 211 (-3.3A)NoneNoneNone | 1.48A | 5b1bN-3kkyA:undetectable5b1bP-3kkyA:undetectable | 5b1bN-3kkyA:17.325b1bP-3kkyA:19.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5D4U_A_SAMA301_0 (UNCHARACTERIZEDPROTEIN MJ0489) |
3wd7 | TYPE III POLYKETIDESYNTHASES ACRIDONESYNTHASE (Citrusxmicrocarpa) | 5 / 12 | GLY A 256ILE A 258THR A 264GLY A 262GLY A 211 | GLY A 256 ( 0.0A)ILE A 258 ( 0.4A)THR A 264 ( 0.8A)GLY A 262 ( 0.0A)GLY A 211 ( 0.0A) | 1.11A | 5d4uA-3wd7A:undetectable | 5d4uA-3wd7A:21.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5E8Q_A_FOLA201_1 (DIHYDROFOLATEREDUCTASE) |
1yz4 | DUAL SPECIFICITYPHOSPHATASE-LIKE 15ISOFORM A (Homosapiens) | 3 / 3 | ASP A 57LEU A 14ARG A 122 | SO4 A 211 ( 4.2A)NoneNone | 0.84A | 5e8qA-1yz4A:undetectable | 5e8qA-1yz4A:20.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5G48_A_1FLA1375_1 (DNA POLYMERASE IIISUBUNIT BETA) |
5xyi | 40S RIBOSOMALPROTEIN S17-B,PUTATIVE (Trichomonasvaginalis) | 4 / 8 | THR R 55LEU R 57ILE R 17LEU R 61 | C 21198 ( 3.9A)NoneNoneNone | 0.93A | 5g48A-5xyiR:undetectable | 5g48A-5xyiR:18.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5GLM_A_ACTA613_0 (GLYCOSIDE HYDROLASEFAMILY 43) |
2yof | THYMIDYLATE KINASE (Plasmodiumfalciparum) | 3 / 3 | ASP A 17SER A 103TYR A 107 | 74W A 211 (-2.6A)74W A 211 ( 4.4A)74W A 211 (-3.5A) | 0.83A | 5glmA-2yofA:undetectable | 5glmA-2yofA:17.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HGC_A_HCYA501_1 (SERPIN) |
5xxu | RIBOSOMAL PROTEINUS10RIBOSOMAL PROTEINUS14 (Toxoplasmagondii) | 5 / 12 | VAL d 21THR U 179PHE U 194GLN d 47PHE d 41 | None G 21194 ( 4.2A)NoneNoneNone | 1.37A | 5hgcA-5xxud:undetectable | 5hgcA-5xxud:8.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HM8_G_ADNG501_2 (ADENOSYLHOMOCYSTEINASE) |
1k26 | NUDIX HOMOLOG (Pyrobaculumaerophilum) | 4 / 5 | THR A 4GLU A 49THR A 50LEU A 8 | NoneGOL A 211 (-3.7A)NoneNone | 1.23A | 5hm8G-1k26A:undetectable | 5hm8G-1k26A:14.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IKT_A_TLFA601_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5x2v | L-METHIONINEGAMMA-LYASE (Pseudomonasputida) | 3 / 3 | LEU A 341TYR A 114SER A 208 | LLP A 211 ( 4.6A)LLP A 211 ( 3.5A)LLP A 211 ( 2.7A) | 0.84A | 5iktA-5x2vA:undetectable | 5iktA-5x2vA:20.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5JO9_A_SORA302_0 (RIBITOL2-DEHYDROGENASE) |
5ys3 | SUCCINATE-ACETATEPERMEASE (Citrobacterkoseri) | 5 / 12 | TYR A 72LEU A 103GLY A 104VAL A 108LEU A 138 | ACT A 203 (-4.0A)ACT A 201 ( 4.9A)78M A 211 ( 4.0A)78M A 211 (-4.5A)ACT A 201 (-4.1A) | 1.39A | 5jo9A-5ys3A:undetectable | 5jo9A-5ys3A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5JW1_B_CELB602_2 (PROSTAGLANDIN G/HSYNTHASE 2) |
4cyf | PANTETHEINASE (Homosapiens) | 4 / 6 | VAL A 248SER A 252ILE A 214PHE A 234 | NoneNoneCSO A 211 ( 3.9A)CSO A 211 ( 4.0A) | 0.99A | 5jw1B-4cyfA:undetectable | 5jw1B-4cyfA:21.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5L5F_Y_BO2Y301_1 (PROTEASOME SUBUNITBETATYPE-8,PROTEASOMESUBUNIT BETA TYPE-5PROTEASOME SUBUNITBETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETA TYPE-6) |
1t6p | PHENYLALANINEAMMONIA-LYASE (Rhodotorulatoruloides) | 4 / 8 | THR A 513ALA A 506ASP A 214SER A 210 | NoneNone175 A 211 ( 4.2A)175 A 211 ( 4.7A) | 1.10A | 5l5fY-1t6pA:undetectable5l5fZ-1t6pA:undetectable | 5l5fY-1t6pA:14.895l5fZ-1t6pA:16.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5L6E_A_SAMA601_0 (N6-ADENOSINE-METHYLTRANSFERASE 70 KDASUBUNIT) |
2xcm | CYTOSOLIC HEAT SHOCKPROTEIN 90 (Hordeumvulgare) | 5 / 12 | ILE A 119LEU A 110PHE A 106GLY A 123GLY A 120 | NoneNoneNoneADP A1211 (-2.9A) MG A1212 ( 4.9A) | 1.18A | 5l6eA-2xcmA:undetectable | 5l6eA-2xcmA:23.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5NZW_A_9F2A1102_1 (DNA CROSS-LINKREPAIR 1A PROTEIN) |
2xf4 | HYDROXYACYLGLUTATHIONE HYDROLASE (Salmonellaenterica) | 5 / 10 | HIS A 56HIS A 58HIS A 61HIS A 132ASP A 151 | NonePG4 A1212 ( 3.7A) ZN A1211 (-3.3A)None ZN A1211 (-2.4A) | 0.51A | 5nzwA-2xf4A:2.4 | 5nzwA-2xf4A:21.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5O96_C_SAMC501_0 (RIBOSOMAL RNA SMALLSUBUNITMETHYLTRANSFERASE E) |
2btd | PTS-DEPENDENTDIHYDROXYACETONEKINASE (Escherichiacoli) | 4 / 7 | GLY A 126SER A 164THR A 129ALA A 194 | NoneNoneADP A1211 (-3.6A)None | 0.79A | 5o96C-2btdA:undetectable | 5o96C-2btdA:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5OEX_A_CUA604_0 (THIOCYANATEDEHYDROGENASE) |
1soj | CGMP-INHIBITED3',5'-CYCLICPHOSPHODIESTERASE B (Homosapiens) | 3 / 3 | HIS A 741HIS A 737HIS A 825 | MG A2123 (-3.0A)IBM A2111 ( 4.8A)None | 1.00A | 5oexA-1sojA:undetectable | 5oexA-1sojA:21.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5SYJ_A_NIZA810_1 (CATALASE-PEROXIDASE) |
5x2v | L-METHIONINEGAMMA-LYASE (Pseudomonasputida) | 4 / 6 | ARG A 265HIS A 269LEU A 341SER A 214 | NoneNoneLLP A 211 ( 4.6A)LLP A 211 ( 4.7A) | 1.09A | 5syjA-5x2vA:undetectable | 5syjA-5x2vA:20.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5SYJ_B_NIZB810_1 (CATALASE-PEROXIDASE) |
5x2v | L-METHIONINEGAMMA-LYASE (Pseudomonasputida) | 4 / 6 | ARG A 265HIS A 269LEU A 341SER A 214 | NoneNoneLLP A 211 ( 4.6A)LLP A 211 ( 4.7A) | 1.13A | 5syjB-5x2vA:undetectable | 5syjB-5x2vA:20.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TDZ_A_ADNA905_1 (ATP-CITRATE SYNTHASE) |
2btd | PTS-DEPENDENTDIHYDROXYACETONEKINASE (Escherichiacoli) | 4 / 6 | THR A 195ASP A 191LEU A 29ASP A 30 | NoneADP A1211 (-2.5A)None MG A1212 ( 2.3A) | 1.10A | 5tdzA-2btdA:undetectable | 5tdzA-2btdA:19.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TE8_C_08JC602_1 (CYTOCHROME P450 3A4) |
2q04 | ACETOIN UTILIZATIONPROTEIN (Exiguobacteriumsibiricum) | 4 / 7 | LEU A 97ALA A 99ILE A 54LEU A 78 | None CA A 211 ( 4.8A)NoneNone | 0.82A | 5te8C-2q04A:undetectable | 5te8C-2q04A:18.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5U6M_A_SALA503_1 (UDP-GLYCOSYLTRANSFERASE 74F2) |
3kky | SUPEROXIDE DISMUTASE[MN] (Deinococcusradiodurans) | 4 / 7 | THR A 22HIS A 26PHE A 83MET A 87 | None MN A 211 (-3.3A)NoneNone | 1.37A | 5u6mA-3kkyA:undetectable | 5u6mA-3kkyA:17.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5U6M_B_SALB503_1 (UDP-GLYCOSYLTRANSFERASE 74F2) |
3kky | SUPEROXIDE DISMUTASE[MN] (Deinococcusradiodurans) | 4 / 7 | THR A 22HIS A 26PHE A 83MET A 87 | None MN A 211 (-3.3A)NoneNone | 1.35A | 5u6mB-3kkyA:undetectable | 5u6mB-3kkyA:17.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UL4_A_SAMA803_0 (OXSB PROTEIN) |
3dez | OROTATEPHOSPHORIBOSYLTRANSFERASE (Streptococcusmutans) | 5 / 12 | ALA A 74ARG A 40GLY A 77GLY A 81ILE A 83 | NoneSO4 A 211 (-4.1A)NoneNoneNone | 1.14A | 5ul4A-3dezA:2.7 | 5ul4A-3dezA:17.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VKQ_B_PCFB1806_0 (NO MECHANORECEPTORPOTENTIAL C ISOFORML) |
2j5b | TYROSYL-TRNASYNTHETASE (Acanthamoebapolyphagamimivirus) | 4 / 6 | ILE A 11ILE A 45LEU A 213HIS A 211 | ILE A 11 ( 0.7A)ILE A 45 ( 0.7A)LEU A 213 ( 0.6A)HIS A 211 ( 1.0A) | 0.99A | 5vkqB-2j5bA:undetectable5vkqC-2j5bA:undetectable | 5vkqB-2j5bA:12.285vkqC-2j5bA:12.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VKQ_C_PCFC1807_0 (NO MECHANORECEPTORPOTENTIAL C ISOFORML) |
2j5b | TYROSYL-TRNASYNTHETASE (Acanthamoebapolyphagamimivirus) | 4 / 6 | ILE A 11ILE A 45LEU A 213HIS A 211 | ILE A 11 ( 0.7A)ILE A 45 ( 0.7A)LEU A 213 ( 0.6A)HIS A 211 ( 1.0A) | 0.96A | 5vkqC-2j5bA:undetectable5vkqD-2j5bA:undetectable | 5vkqC-2j5bA:12.285vkqD-2j5bA:12.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VLM_E_CVIE301_1 (REGULATORY PROTEINTETR) |
3cr3 | PTS-DEPENDENTDIHYDROXYACETONEKINASE, ADP-BINDINGSUBUNIT DHAL (Lactococcuslactis) | 4 / 7 | GLN A 118GLY A 120TYR A 83ASP A 174 | NoneNoneNoneADP A1211 (-2.7A) | 0.90A | 5vlmE-3cr3A:undetectable | 5vlmE-3cr3A:21.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VOO_E_C2FE3001_0 (5-METHYLTETRAHYDROFOLATE HOMOCYSTEINES-METHYLTRANSFERASE) |
1yio | RESPONSE REGULATORYPROTEIN (Pseudomonasfluorescens) | 5 / 12 | ARG A 44GLY A 50GLY A 98ARG A 130ILE A 79 | None HG A 211 (-4.1A)NoneNoneNone | 1.05A | 5vooE-1yioA:2.8 | 5vooE-1yioA:22.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5X19_P_CHDP306_0 (CYTOCHROME C OXIDASESUBUNIT 1CYTOCHROME C OXIDASESUBUNIT 3) |
3kky | SUPEROXIDE DISMUTASE[MN] (Deinococcusradiodurans) | 4 / 6 | HIS A 26ASP A 12TYR A 9HIS A 30 | MN A 211 (-3.3A)NoneNoneNone | 1.49A | 5x19N-3kkyA:undetectable5x19P-3kkyA:undetectable | 5x19N-3kkyA:17.325x19P-3kkyA:19.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5YOD_H_BEZH201_0 (NS3 PROTEASE) |
3ghg | FIBRINOGEN GAMMACHAIN (Homosapiens) | 4 / 5 | HIS C 343SER C 332TYR C 211GLY C 333 | HIS C 343 ( 1.0A)SER C 332 ( 0.0A)TYR C 211 ( 1.3A)GLY C 333 ( 0.0A) | 1.37A | 5yodH-3ghgC:undetectable | 5yodH-3ghgC:19.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZJ8_A_9DCA303_0 (METALLO-BETA-LACTAMASE TYPE 2) |
2xf4 | HYDROXYACYLGLUTATHIONE HYDROLASE (Salmonellaenterica) | 4 / 8 | HIS A 58ASP A 60HIS A 132HIS A 192 | PG4 A1212 ( 3.7A) ZN A1211 ( 2.8A)None ZN A1211 (-3.3A) | 0.84A | 5zj8A-2xf4A:18.7 | 5zj8A-2xf4A:21.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AG0_A_ACRA606_0 (ALPHA-AMYLASE) |
3rq0 | GLYCOSYL HYDROLASESFAMILY PROTEIN 16 (Mycolicibacteriumsmegmatis) | 5 / 7 | GLY A 251GLY A 252GLY A 136GLY A 246GLY A 158 | NoneNoneNoneNone211 A 280 (-3.5A) | 0.98A | 6ag0A-3rq0A:undetectable | 6ag0A-3rq0A:13.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AP6_A_TLFA300_0 (PROBABLESTRIGOLACTONEESTERASE DAD2) |
4cyf | PANTETHEINASE (Homosapiens) | 5 / 12 | VAL A 224PHE A 234PHE A 250VAL A 260PHE A 262 | NoneCSO A 211 ( 4.0A)NoneNoneNone | 1.30A | 6ap6A-4cyfA:undetectable | 6ap6A-4cyfA:18.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AP6_B_TLFB300_0 (PROBABLESTRIGOLACTONEESTERASE DAD2) |
4cyf | PANTETHEINASE (Homosapiens) | 5 / 12 | VAL A 224PHE A 234PHE A 250VAL A 260PHE A 262 | NoneCSO A 211 ( 4.0A)NoneNoneNone | 1.32A | 6ap6B-4cyfA:undetectable | 6ap6B-4cyfA:18.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUU_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
3rq0 | GLYCOSYL HYDROLASESFAMILY PROTEIN 16 (Mycolicibacteriumsmegmatis) | 4 / 7 | VAL A 184TRP A 156TRP A 138GLU A 155 | None211 A 280 ( 4.7A)GOL A 278 (-3.7A)GOL A 278 (-3.4A) | 1.08A | 6auuA-3rq0A:undetectable6auuB-3rq0A:undetectable | 6auuA-3rq0A:15.446auuB-3rq0A:15.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AZ3_1_PAR11803_1 (RRNA ALPHARIBOSOMAL PROTEINEL18) |
3clv | RAB5 PROTEIN,PUTATIVE (Plasmodiumfalciparum) | 3 / 3 | SER A 21LYS A 20SER A 22 | GDP A 211 (-2.6A)GDP A 211 (-2.8A)GDP A 211 (-2.7A) | 0.81A | 6az3P-3clvA:undetectable | 6az3P-3clvA:19.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BXL_B_SAMB401_0 (2-(3-AMINO-3-CARBOXYPROPYL)HISTIDINESYNTHASE) |
5jb3 | 30S RIBOSOMALPROTEIN S10 (Pyrococcusabyssi) | 5 / 12 | LEU L 72VAL L 90ARG L 71VAL L 19ASP L 17 | NoneNone G 21112 ( 4.0A)None G 21112 ( 4.7A) | 1.25A | 6bxlB-5jb3L:undetectable | 6bxlB-5jb3L:16.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6C06_D_FI8D1404_1 (DNA-DIRECTED RNAPOLYMERASE SUBUNITBETA') |
3vib | MTRR (Neisseriagonorrhoeae) | 3 / 3 | ARG A 137LYS A 167ARG A 98 | NonePO4 A 211 ( 2.6A)None | 1.27A | 6c06D-3vibA:3.5 | 6c06D-3vibA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6E43_A_BEZA502_0 (INDOLEAMINE2,3-DIOXYGENASE 1) |
5svd | NUCLEOLAR PROTEIN 9 (Saccharomycescerevisiae) | 4 / 6 | LEU A 211LEU A 208ARG A 207HIS A 204 | LEU A 211 ( 0.6A)LEU A 208 ( 0.5A)ARG A 207 ( 0.6A)HIS A 204 ( 1.0A) | 0.90A | 6e43A-5svdA:1.7 | 6e43A-5svdA:21.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6E43_B_BEZB502_0 (INDOLEAMINE2,3-DIOXYGENASE 1) |
5svd | NUCLEOLAR PROTEIN 9 (Saccharomycescerevisiae) | 4 / 6 | LEU A 211LEU A 208ARG A 207HIS A 204 | LEU A 211 ( 0.6A)LEU A 208 ( 0.5A)ARG A 207 ( 0.6A)HIS A 204 ( 1.0A) | 0.92A | 6e43B-5svdA:3.3 | 6e43B-5svdA:21.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6E43_D_BEZD502_0 (INDOLEAMINE2,3-DIOXYGENASE 1) |
5svd | NUCLEOLAR PROTEIN 9 (Saccharomycescerevisiae) | 4 / 6 | LEU A 211LEU A 208ARG A 207HIS A 204 | LEU A 211 ( 0.6A)LEU A 208 ( 0.5A)ARG A 207 ( 0.6A)HIS A 204 ( 1.0A) | 0.85A | 6e43D-5svdA:1.9 | 6e43D-5svdA:21.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EBP_B_DAHB123_0 (RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE,BETA SUBUNIT) |
5hiu | GTPASEACTIVATOR-LIKEPROTEIN (Chaetomiumthermophilum) | 5 / 10 | PHE A 207LEU A 210THR A 211GLY A 276ILE A 274 | PHE A 207 ( 1.3A)LEU A 210 ( 0.5A)THR A 211 ( 0.8A)GLY A 276 ( 0.0A)ILE A 274 ( 0.7A) | 0.87A | 6ebpB-5hiuA:undetectable | 6ebpB-5hiuA:9.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EBP_C_DAHC123_0 (RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE,BETA SUBUNIT) |
5hiu | GTPASEACTIVATOR-LIKEPROTEIN (Chaetomiumthermophilum) | 5 / 10 | PHE A 207LEU A 210THR A 211GLY A 276ILE A 274 | PHE A 207 ( 1.3A)LEU A 210 ( 0.5A)THR A 211 ( 0.8A)GLY A 276 ( 0.0A)ILE A 274 ( 0.7A) | 0.89A | 6ebpC-5hiuA:undetectable | 6ebpC-5hiuA:9.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EBP_D_DAHD123_0 (RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE,BETA SUBUNIT) |
5hiu | GTPASEACTIVATOR-LIKEPROTEIN (Chaetomiumthermophilum) | 6 / 10 | PHE A 207LEU A 210THR A 211GLY A 276ILE A 274ILE A 262 | PHE A 207 ( 1.3A)LEU A 210 ( 0.5A)THR A 211 ( 0.8A)GLY A 276 ( 0.0A)ILE A 274 ( 0.7A)ILE A 262 ( 0.7A) | 0.97A | 6ebpD-5hiuA:undetectable | 6ebpD-5hiuA:9.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EBZ_A_DAHA123_0 (RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE,BETA SUBUNIT) |
5hiu | GTPASEACTIVATOR-LIKEPROTEIN (Chaetomiumthermophilum) | 6 / 11 | PHE A 207LEU A 210THR A 211GLY A 276ILE A 274ILE A 262 | PHE A 207 ( 1.3A)LEU A 210 ( 0.5A)THR A 211 ( 0.8A)GLY A 276 ( 0.0A)ILE A 274 ( 0.7A)ILE A 262 ( 0.7A) | 0.98A | 6ebzA-5hiuA:undetectable | 6ebzA-5hiuA:9.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EBZ_B_DAHB123_0 (RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE,BETA SUBUNIT) |
5hiu | GTPASEACTIVATOR-LIKEPROTEIN (Chaetomiumthermophilum) | 6 / 11 | PHE A 207LEU A 210THR A 211GLY A 276ILE A 274ILE A 262 | PHE A 207 ( 1.3A)LEU A 210 ( 0.5A)THR A 211 ( 0.8A)GLY A 276 ( 0.0A)ILE A 274 ( 0.7A)ILE A 262 ( 0.7A) | 1.01A | 6ebzB-5hiuA:undetectable | 6ebzB-5hiuA:9.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EBZ_C_DAHC123_0 (RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE,BETA SUBUNIT) |
5hiu | GTPASEACTIVATOR-LIKEPROTEIN (Chaetomiumthermophilum) | 6 / 11 | PHE A 207LEU A 210THR A 211GLY A 276ILE A 274ILE A 262 | PHE A 207 ( 1.3A)LEU A 210 ( 0.5A)THR A 211 ( 0.8A)GLY A 276 ( 0.0A)ILE A 274 ( 0.7A)ILE A 262 ( 0.7A) | 1.04A | 6ebzC-5hiuA:undetectable | 6ebzC-5hiuA:9.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EBZ_D_DAHD123_0 (RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE,BETA SUBUNIT) |
5hiu | GTPASEACTIVATOR-LIKEPROTEIN (Chaetomiumthermophilum) | 6 / 11 | PHE A 207LEU A 210THR A 211GLY A 276ILE A 274ILE A 262 | PHE A 207 ( 1.3A)LEU A 210 ( 0.5A)THR A 211 ( 0.8A)GLY A 276 ( 0.0A)ILE A 274 ( 0.7A)ILE A 262 ( 0.7A) | 0.99A | 6ebzD-5hiuA:undetectable | 6ebzD-5hiuA:9.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EXI_D_ADND502_1 (ADENOSYLHOMOCYSTEINASE) |
3qvi | HISTO-ASPARTICPROTEASE (Plasmodiumfalciparum) | 3 / 3 | LEU A 128ASN A 211LEU A 184 | LEU A 128 (-0.6A)ASN A 211 ( 0.6A)LEU A 184 ( 0.5A) | 0.72A | 6exiD-3qviA:undetectable | 6exiD-3qviA:10.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6FBP_B_ADNB404_0 (S-ADENOSYLMETHIONINESYNTHASE ISOFORMTYPE-2) |
1t6p | PHENYLALANINEAMMONIA-LYASE (Rhodotorulatoruloides) | 5 / 12 | ASP A 396ILE A 171PRO A 217SER A 175ASP A 214 | NoneNoneNoneNone175 A 211 ( 4.2A) | 1.45A | 6fbpA-1t6pA:undetectable6fbpB-1t6pA:undetectable | 6fbpA-1t6pA:8.456fbpB-1t6pA:8.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6FDY_U_DB8U302_1 (-) |
5x2v | L-METHIONINEGAMMA-LYASE (Pseudomonasputida) | 5 / 9 | LEU A 198PRO A 192VAL A 225SER A 208LEU A 213 | NoneNoneNoneLLP A 211 ( 2.7A)None | 1.40A | 6fdyU-5x2vA:undetectable | 6fdyU-5x2vA:21.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6FHW_A_ACRA801_2 (GLUCOAMYLASE P) |
2jcs | DEOXYNUCLEOSIDEKINASE (Drosophilamelanogaster) | 3 / 3 | TRP A 57GLU A 55GLU A 104 | NoneNone MG A1211 ( 2.9A) | 0.97A | 6fhwA-2jcsA:undetectable | 6fhwA-2jcsA:13.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6GB9_A_ACTA508_0 (MOLYBDOPTERINBIOSYNTHESIS PROTEINCNX1) |
1rrv | GLYCOSYLTRANSFERASEGTFD (Amycolatopsisorientalis) | 3 / 3 | VAL A 209ALA A 211GLN A 206 | VAL A 209 ( 0.6A)ALA A 211 ( 0.0A)GLN A 206 ( 0.6A) | 0.69A | 6gb9A-1rrvA:4.4 | 6gb9A-1rrvA:26.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6GNG_A_QPSA601_2 (-) |
3ica | PHENYLALANYL-TRNASYNTHETASE BETACHAIN (Porphyromonasgingivalis) | 5 / 12 | GLU A 68GLY A 66TYR A 33GLU A 203GLY A 113 | GOL A 211 (-3.0A)NoneNoneNoneNone | 1.36A | 6gngA-3icaA:undetectable | 6gngA-3icaA:17.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6GP2_A_DAHA126_0 (RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASEBETA CHAIN) |
5hiu | GTPASEACTIVATOR-LIKEPROTEIN (Chaetomiumthermophilum) | 6 / 11 | PHE A 207LEU A 210THR A 211GLY A 276ILE A 274ILE A 262 | PHE A 207 ( 1.3A)LEU A 210 ( 0.5A)THR A 211 ( 0.8A)GLY A 276 ( 0.0A)ILE A 274 ( 0.7A)ILE A 262 ( 0.7A) | 0.95A | 6gp2A-5hiuA:undetectable | 6gp2A-5hiuA:10.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6GP2_B_DAHB126_0 (RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASEBETA CHAIN) |
5hiu | GTPASEACTIVATOR-LIKEPROTEIN (Chaetomiumthermophilum) | 6 / 11 | PHE A 207LEU A 210THR A 211GLY A 276ILE A 274ILE A 262 | PHE A 207 ( 1.3A)LEU A 210 ( 0.5A)THR A 211 ( 0.8A)GLY A 276 ( 0.0A)ILE A 274 ( 0.7A)ILE A 262 ( 0.7A) | 0.86A | 6gp2B-5hiuA:undetectable | 6gp2B-5hiuA:10.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6JMJ_A_ASCA201_0 (PHOSPHOPANTETHEINEADENYLYLTRANSFERASE) |
2xcm | CYTOSOLIC HEAT SHOCKPROTEIN 90 (Hordeumvulgare) | 4 / 5 | GLY A 172THR A 173SER A 41SER A 40 | NoneADP A1211 (-3.4A)NoneADP A1211 ( 4.0A) | 1.12A | 6jmjA-2xcmA:undetectable | 6jmjA-2xcmA:21.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MN4_A_AM2A301_0 (AMINOGLYCOSIDEN(3)-ACETYLTRANSFERASE, AAC(3)-IVA) |
2xf4 | HYDROXYACYLGLUTATHIONE HYDROLASE (Salmonellaenterica) | 4 / 8 | ASP A 151HIS A 168HIS A 56ASP A 162 | ZN A1211 (-2.4A)NoneNoneNone | 1.06A | 6mn4A-2xf4A:undetectable | 6mn4A-2xf4A:23.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6NKN_C_CHDC301_0 (CYTOCHROME C OXIDASESUBUNIT 1CYTOCHROME C OXIDASESUBUNIT 3) |
3kky | SUPEROXIDE DISMUTASE[MN] (Deinococcusradiodurans) | 4 / 6 | HIS A 26ASP A 12TYR A 9HIS A 30 | MN A 211 (-3.3A)NoneNoneNone | 1.50A | 6nknA-3kkyA:1.76nknC-3kkyA:undetectable | 6nknA-3kkyA:17.326nknC-3kkyA:19.32 |